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BRAIN TUMOR TARGET VOLUME DETERMINATION FOR RADIATION 
THERAPY TREATMENT PLANNING THROUGH THE USE OF AUTOMATED 
MRI SEGMENTATION 
 
Gloria Patrika Mazzara 
 
ABSTRACT 
Radiation therapy seeks to effectively irradiate the tumor cells while minimizing 
the dose to adjacent normal cells.  Prior research found that the low success rates for 
treating brain tumors would be improved with higher radiation doses to the tumor area.  
This is feasible only if the target volume can be precisely identified.  However, the 
definition of tumor volume is still based on time-intensive, highly subjective manual 
outlining by radiation oncologists.  In this study the effectiveness of two automated 
Magnetic Resonance Imaging (MRI) segmentation methods, k-Nearest Neighbors (kNN) 
and Knowledge-Guided (KG), in determining the Gross Tumor Volume (GTV) of brain 
tumors for use in radiation therapy was assessed.  Three criteria were applied: accuracy 
of the contours; quality of the resulting treatment plan in terms of dose to the tumor; and 
a novel treatment plan evaluation technique based on post-treatment images.   
The kNN method was able to segment all cases while the KG method was limited 
to enhancing tumors and gliomas with clear enhancing edges.  Various software 
applications were developed to create a closed smooth contour that encompassed the 
tumor pixels from the segmentations and to integrate these results into the treatment 
planning software.  A novel, probabilistic measurement of accuracy was introduced to 
viii 
compare the agreement of the segmentation methods with the weighted average physician 
volume.  Both computer methods under-segment the tumor volume when compared with 
the physicians but performed within the variability of manual contouring (28% ± 12% for 
inter-operator variability).     
Computer segmentations were modified vertically to compensate for their under-
segmentation.  When comparing radiation treatment plans designed from physician-
defined tumor volumes with treatment plans developed from the modified segmentation 
results, the reference target volume was irradiated within the same level of conformity.  
Analysis of the plans based on post- treatment MRI showed that the segmentation plans 
provided similar dose coverage to areas being treated by the original treatment plans. 
This research demonstrates that computer segmentations provide a feasible route 
to automatic target volume definition.  Because of the lower variability and greater 
efficiency of the automated techniques, their use could lead to more precise plans and 
better prognosis for brain tumor patients.
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CHAPTER I 
 
INTRODUCTION 
The brain is the body’s single most critical and indispensable component.  Its 
central role in the functioning of the body explains the importance of improving 
treatment protocols for primary brain tumors, or gliomas, since this form of cancer results 
in significant neuronal losses which frequently result in the death of the patient.  Brain 
cancer will strike down five to ten people out of every 100,000 (1).  An estimated 17,000 
new malignant primary brain tumors were diagnosed in 2002 in the United States (2).   
Brain tumors are the leading cause of death among childhood cancers, the second leading 
cause of cancer deaths in males between the ages of 20-39, and the fifth leading cause of 
cancer deaths in women between the ages of 20-39.  The two year survival rate for 
patients diagnosed with glioblastoma multiforme (GBM), one of the most common 
malignant brain tumors, is less than 9%; and it is only 35% for patients with other types 
of brain tumors (3).  The rate of mortality due to brain malignancies remains high despite 
significant advances in early diagnosis brought about by the use of computed tomography 
(CT) and magnetic resonance imaging (MRI).   
Accordingly, brain cancer is a particularly deadly disease which current treatment 
modalities are relatively ineffective in curing or even controlling.  Current treatment 
protocols for gliomas generally call for tumor removal through surgical procedures 
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followed by irradiation of the tumor bed.  This study focuses on the latter part of this 
common treatment regime.   
External radiation therapy uses high energy x-rays externally delivered from 
multiple directions to damage critical biological molecules in cancerous cells.  
Unfortunately, when irradiating tumors, normal healthy cells may also receive damaging 
radiation.  This irradiation could cause critical side effects, including loss of vision or 
reduced brain function.  Thus, the goal of radiation therapy is to effectively irradiate the 
tumor area, or target volume, while minimizing the radiation dose absorbed by adjacent 
normal tissues and organs.  A radiation treatment is considered successful if tumor 
control is achieved, i.e. cancer cells are inhibited from dividing or reproducing, without 
undue damage to surrounding healthy tissue.  The long-term goal of radiation treatment is 
to prevent any tumor recurrence or growth. 
Radiation treatment protocols have evolved to deliver radiation that conforms 
closely to the three-dimensional (3D) shape of the treatment volume; this treatment 
protocol is commonly referred to as three-dimensional conformal radiation treatment or 
3D-CRT.  The key to successful 3D-CRT treatment is achieving the highest possible 
degree of accuracy when defining the tumor volume (or target volume).  One reason for 
the disappointing results of current brain radiation therapy techniques is an inability to 
sufficiently irradiate the target volume to kill the cancerous cells.  Gliomas are relatively 
resistant to radiation when compared with other types of tumors (4).  Research has showed 
that most brain tumor recurrences are located within the primary tumor area (5-8).  Over 
the last few years, a number of studies have addressed the issue of brain radiation dose 
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escalation.  Escalating the dose to the tumor area could increase local control thus 
prolonging the progression-free interval for such cases (3.9,10).  This increase in dose 
delivery would be feasible only if the target area could be more clearly identified and 
segregated from surrounding healthy tissue for treatment purposes (9).   
Radiation oncologists traditionally model the brain treatment target volume 
through a time-intensive manual procedure involving the outlining of the palpable or 
visible extent of the tumor (gross tumor volume, GTV) on numerous consecutive two-
dimensional images, or “slices,” using either CT or MRI.  While the trial and error part of 
modern treatment planning has, for the most part, been automated, the effort required 
from the radiation oncologists to produce accurate 3-D treatment plans has only been 
increased.   Limitations remain inherent in the current methods of tumor delineation 
making it virtually impossible for different radiation oncologists to reproduce consistent 
results (11).  Various studies have demonstrated the existence of this large variation in 
target volume definitions produced by different physicians using both CT and MR images 
(6,12,13).  Inadequate 3-D target definition may lead to an inability to exploit the full 
potential of advanced treatment planning techniques or a loss of tumor control due to 
geographical misses with radiation doses. (14).  Additionally, imprecise identification of 
the tumor area prevent the types of dose escalations to the tumor bed which could 
significantly improve treatment efficacy (2,9,3).  
Because of the highly technical yet repetitious nature of manual outlining, the 
process offers an excellent opportunity for the creation of an automated expert system 
utilizing a computerized system which could both reduce the subjectivity inherent in the 
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manual process and conserve the scarce time resources of radiation oncologists.  
Automatic segmentation of MR images offers the potential to accurately define complex 
treatment volumes, to speed the contouring process in radiation therapy treatment 
planning, and to provide a standardized and reproducible tumor measurement protocol 
that can be employed by geographically diverse facilities and physicians. 
Automating the MR brain tumor segmentation process is extremely difficult due 
to the complexities inherent in modeling the tumor bed as well as changes in the 
magnetic resonance characteristics of normal tissues (15,16).  Most reported MRI 
segmentation techniques have been pixel based, i.e., each image pixel is individually 
classified into a tissue class.  At our institution, several techniques of MR segmentation 
have been developed and evaluated specifically for use with brain tumors.  These 
methods use the information derived from several magnetic resonance contrasts (i.e. 
multi-spectral data).  Supervised automated segmentation methods require an operator to 
select regions of interest (ROIs) on each slice of multi-spectral (MS) MRI data; these 
regions are in turn used to train the automated classifier.  One of these methods, the “k 
nearest neighbor” (kNN) system, has been shown to perform better than other tested 
supervised methods and has been used by many researchers for automated brain 
segmentation (15,17,18).  Unsupervised techniques of MR segmentation do not require 
operator input for the processing of each data set.  To automate the tumor volume 
determination, Clark, Hall and Goldgof encoded knowledge of the pixel intensity and 
spatial relationships in the images to create a fully-automated segmentation system 
known as the Knowledge Guided (KG) Method (19,20).  Both the kNN and KG 
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segmentation methods have been clinically applied as a technique for more accurately 
measuring tumor volume variation in the brain (18,21).  To date, no fully automatic 
protocol for outlining of treatment volumes for radiation therapy has been developed.   
The goal of this study was to bring state-of-the-art engineering into the realm of 
radiation oncology treatment planning.  This work evaluates the performance of kNN as a 
representative of operator assisted semi-automated segmentation and the KG system as a 
promising candidate for fully automated GTV determinations.  Specifically, the goal was 
to ascertain if the two types of computer segmentations methods could be used for 
radiation therapy treatment planning, and, if not, which improvements are required to 
achieve this goal.  This study developed a technique for incorporating the automated 
segmentation methods into radiation treatment planning and devised an evaluation 
mechanism that could be used to assess the effectiveness of these new contouring 
techniques.  The study process is represented in Figure 1. 
This dissertation is divided in three sections.  The first section (Chapter II) 
evaluates the current practice of tumor outlining by radiation oncologists for radiation 
therapy treatment planning.  An evaluation of the intra- and inter- operator variability was 
performed.  The results of this evaluation form the basis for the second section of the 
study (Chapter III), which describes the methods for incorporating two different types of 
MRI segmentation techniques (kNN and KG) for radiation GTV definition into clinical 
radiation therapy treatment (a software toolkit was developed as part of this study to 
integrate the segmentation methods into radiation therapy planning).  A study of the level 
of agreement of the automatic segmentation contours with respect to the physician 
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outlines was performed.  Finally, a novel evaluation technique was developed to quantify 
results from the physician contours and perform the comparison with the segmentation 
contours.  Additionally, this section presents conclusions on how the automated systems 
for generating segmentation volumes could be improved to reach the goal of producing 
reliable outlines of treatment volumes without any human input.    
The final section (Chapter IV) uses the data and insights from the previous section 
to evaluate the automated segmentation routines in the clinical radiation therapy setting.  
A comparison of treatment plans designed using physician defined tumor volumes with 
treatment plans developed from computer segmentation was performed.  The differences 
between physicians and automatic segmentations in terms of delivered dose were 
calculated.  This final section also provides the design of a novel evaluation mechanism 
to determine the accuracy of treatment planning of automatic segmentations with respect 
to the actual patient treatment based on follow-up imaging (Figure 1).  This evaluation 
scheme could be applied to any imaging modality and would serve the purpose of 
evaluating the applicability of any automatic contouring method for radiation therapy. 
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CHAPTER II 
 
EVALUATING CURRENT PRACTICE:  MANUAL OUTLINING  
BY RADIATION ONCOLOGISTS 
 
II.1. Introduction: manual outlining in radiation oncology 
Three-dimensional conformal radiation treatment (3D-CRT) planning and 
delivery has the general goal of conforming the shape of a prescribed dose volume to the 
shape of a three-dimensional target volume.  The success of the radiation treatment relies 
on the accurate determination of the target volume.  Failure to assess the extent of the 
disease or to include too much normal tissue could lead to treatment failure or 
unnecessary damage of healthy tissues.   
The radiation oncologist is the physician in charge of a patient’s radiation 
treatment.  Radiation oncologists traditionally model the brain gross tumor target volume 
(GTV) through a time-intensive manual procedure involving the outlining of the tumor 
on numerous two-dimensional images or “slices”.  The introduction of CT and MRI in 
the last few years has contributed to improvements in the accuracy of delineating tumor 
extensions.  However, the variation in contouring of target volumes between different 
observers can range from 5% to 32% (12,13,22).  Therefore, significant limitations remain in 
both the accurate delineation of tumor volumes and in the ability of different radiation 
oncologists to reproduce consistent results (11).    
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The aim of this chapter is to measure the variability of radiation oncologists in the 
manual definition of the gross tumor volume.  The results of this analysis are used as the 
basis for comparing the results of automated segmentation methods with the physician 
contours.  This chapter is divided into eight sections.  Section II.2 gives the basis for 
patient selection and demographics.  Sections II.3 and II.4 describe the basis of different 
imaging techniques used in the study.  Sections II.5 and II.6 summarize the methodology 
used to create the contour definitions by physicians and to calculate the accuracy of the 
results, respectively.  Section II.7 gives the results of contouring variability by radiation 
oncologists.  Finally, Section II.8 discusses the results obtained in this chapter and their 
relevance to the remaining chapters of the dissertation. 
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II.2.  Subjects 
Pre-existing MRI and CT data of eleven patients with primary brain cancer 
(glioma) was used as the basis in this study.  The study was approved under the 
University of South Florida (USF) institutional review board #5253 and required no 
patient informed consent since only existing data was used and recorded in such a manner 
that participants could not be identified.  Patient selection was based on available cases 
collected over a period of one year with primary brain cancer (glioma) that had a pre- 
treatment MRI in our clinic and proceeded to have radiation therapy in Moffitt Cancer 
Center.    
The demographics of the patient group are listed in Table 1.  In conformance with 
the standard clinical protocol of Moffitt Cancer Center, these patients were imaged pre-
surgery with MRI and post-surgery with both MRI and CT.  The MRI was used to 
identify and delineate the tumor and the CT was used for radiation therapy treatment 
planning.  Depending upon the treatment protocol selected for each individual patient, the 
MRI images used in connection with this study may have been taken either before or 
after surgery.  The CT was used for 3D radiation treatment planning. 
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Table 1. 
Patient demographics 
 
 
Case Age  Sex  Diagnosis 
 (*) 
Surgery 
(days from 
MRI) 
 MRI 
 Type 
(+) 
Tumor 
  Enhanced 
RT(++) Start 
(days from 
MRI) 
 
1 65 F AO 3 Pre No 165 
2 52 F O 1 Pre No 70 
3 63 F GBM 1 Pre Yes 28 
4 69 F GBM 3 Pre Yes 19 
5 62 F GBM -89 Post Yes 16 
6 47 M GBM -24 Post Yes 10 
7 52 M AO 3 Pre Yes 73 
8 62 F GBM -17 Post Yes 6 
9 80 M GBM 2 Pre Yes 23 
10 47 F GBM -13 Post Yes 7 
11 79 F GBM -4 Post Yes 7 
   
(*)  GBM = Glioblastoma multiforme     (+) Pre  = pre-surgery MRI 
         AO  = Astrocytoma            Post = post-surgery MRI 
         O  =  Oligodendroglioma     (++) RT = radiation therapy 
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II.3. CT and MRI brain images and registration 
 Common for radiation therapy treatment planning, a series of transaxial 
(perpendicular to the long axis of the body) CT images are used for locating both the 
target volume and normal tissues, and for designing the treatment plan.  However, the 
definition of brain tumor volume by CT studies has been found inadequate.  Other 
imaging modalities, such as MRI, have made significant improvement in the detection 
and localization of brain lesions.  It has been demonstrated by various researchers that 
MRI is superior to CT for diagnostic brain imaging (10,11,22,23).  MRI is more sensitive 
than CT in both lesion detection and in the margin delineation of gliomas, as 
demonstrated in the example of Figure 2.   
 
  
CT MRI
Tumor
 
Figure 2. 
Comparison of CT and MRI tumor detection 
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However, CT is the preferred image modality for use in treatment planning since 
it is an x-ray based technique which captures the characteristics of the tissues (electron 
density) as seen by the treatment beams used in radiation oncology (6).  CT images 
provide anatomical information necessary for verification of the treatment plans (14).  
Therefore, CT and MRI are complementary in providing information for brain 
radiotherapy treatment planning.  The use of MRI for treatment volume definition 
together with the electron density information from the CT allows integration of 
anatomical information with tissue information for more accurate 3D treatment planning.  
Thus, the ability to correlate these two imaging modalities through an accurate system of 
image registration becomes essential to maximizing the effectiveness of brain treatment 
protocols.   
Often the registration of different types of images is done manually, i.e. a 
radiation oncologist uses mental reconstruction to superimpose MRI information onto the 
CT data set.  This difficult process, although in common practice, has been recognized as 
a source of inaccuracies and can lead to incorrect information regarding location of the 
tumor volume (22,24,25).  Several computerized techniques have been developed to 
determine the transformation relating MR images to CT images (26-28).  This process, 
known as “image registration”, is a system that determines the 3D coordinate 
transformation to map the two image sets maintaining optimal anatomical identity.   
Frass et. al. describe some of the earliest registration work for treatment planning 
and the technical aspects of integration of MRI into CT-based radiation therapy planning.  
Their approach to image registration was with the use of external fiducials and contour 
13 
matching algorithms (26).  Other more recent computerized methods describe image 
registration based on point matching, surface matching, and interactive matching by 
using anatomical points, anatomical surfaces or outlines of anatomical structures (25,27).  
The accuracy of these methods has been evaluated using phantoms and patient studies 
and are on the order of 1-2 mm.   
The previously described registration methods are not automated.  These depend 
on patient positioning and selection of reference points resulting in a time consuming 
process.  A newer registration algorithm known as the Mutual Information (MI) 
algorithm provides a fully automated registration method without the need to define 
fiducial or anatomical points (29).  The algorithm aims to maximize mutual information of 
the two images.  It attempts to match similarities in the overall shape of the distribution 
of image intensity in a data set.  Quantitative accuracy of the MI registration algorithm 
has been validated by comparing results with registration based on external markers 
(29,30). 
 Various studies have indicated that distortions in magnetic resonance images are on 
the order of 1-2 mm for the skull volume (31).  A recent study showed that errors in the 
location of fiducial markers on MRI after registration with CT were on the order of  
1 mm (32).  This reported error includes components of the registration error and of the 
geometric distortion in MRI.  These results suggest that the geometric distortions in MR 
images are of small magnitude and would not prevent accurate image registration.   
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II.4.  Patient imaging techniques 
 
II.4.a.  CT scanning 
The CT images were obtained using a Siemens CT HiQ spiral scanner (Siemens 
Medical Systems, Germany) with 512x512 pixel images taken at 4 mm spacing from the 
vertex (top of the head) through the treatment area and 8 mm slice thickness through the 
thyroid.  Patients were immobilized using a customized mask together with a head rest 
(MedTec, Orange City, Iowa).  This mask holds the patient in exactly the same position 
during each of the radiation therapy treatments. The CT treatment planning system 
includes MergeCom, the precursor to DICOM data communications.   
II.4.b.  MRI scanning 
The MRI scan was performed on a different day than the CT scan.  The patients 
were imaged in either a 1.5 Tesla GE Signa Horizon (General Electric Company, 
Milwaukee, WI) or a Siemens Magnetom Symphony with fast gradient systems using 
the standard multi-element head coil.  The systems include perfusion imaging software 
as well as DICOM data communications.    
The multi-spectral data set used for MRI segmentation consisted of 5 mm thick 
axial anatomical slices T1-weighted, proton-density- (PD) weighted, and T2-weighted 
images obtained with a field of view (FOV) of 220 mm and reconstructed to a 512 X 512 
pixel image.  The T1-weighted scans used for this study were obtained after 
administration of 0.1 mmol/kg body weight of gadolinium (Gd) MRI contrast material 
(Gd-DTPA) and using a standard spin-echo (SE) sequence with a repetition time 
(TR)/echo time (TE) = 400/8 or 525/17 ms. The PD images were acquired using a spin 
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echo PD-weighted sequence with TR/TE = 3000/7.5 ms or a fluid-attenuated inversion 
recovery (FLAIR) sequence with TR/TE=10002/147 ms or TR/TE=9000/110 ms.  The 
T2 images were acquired using TR/TE=3000/104 ms or TR/TE=4000/96 ms. Radiation 
oncologists used axial post-contrast T1–weighted images to define GTV for cases of 
enhancing tumor or pre-contrast T2-weighted images for cases where no tumor 
enhancement was seen.   
II.4.c.  Image registration 
Both CT and MRI image sets were transferred to Hewlett Packard workstations 
running Computerized Medical Systems (CMS) 3-D treatment planning FOCUS 
software version 2.4.0.   Each image set was then transferred to a Dell Inspiron 7000 
laptop computer equipped with CMS software for image fusion (“Focal Fusion,” 
software release version 1.3) and contouring (“Focal Ease,” software release version 
1.3.0).  The Focal Software suite provides a fully integrated environment for PCs and the 
CMS planning computers, including a full featured contouring program for 3-D 
radiotherapy.  The laptop computer was dedicated to this research.   
The CT and MRI data were registered using the CMS Focal Fusion software.  
Registration was required to allow manual physician contouring on the MRI images.  
The Focal Fusion software utilizes the Mutual Information (MI) algorithm for fully 
automatic image registration, as described in the previous section.  The software also 
incorporates a manual method for pre- or post- interactive adjustment of the registration 
(rotation and translation) to be coupled with the automated registration.  The program 
writes out a file with a transformation matrix to convert MRI data to the CT coordinates. 
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The final MRI image transformation was evaluated and approved by a radiation 
oncologist who specialized in neuro-oncology.  Qualitative assessment was achieved by 
overlay of CT and MR images in axial (“looking up”), coronal (front view), and sagittal 
(side view) planes.  The pertinent interfaces (bone-tissue, tissue-air and bone-air as well 
as different soft tissue interfaces) were visually examined to ensure that all relevant 
interfaces were correctly aligned.  Registration accuracy for all data sets was verified by 
measuring the displacement of three unique anatomical landmarks.  
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II.5.  Radiation oncologist tumor volume definition 
Three radiation oncologists were selected to perform manual contouring of the 
GTV.  The expertise of each radiation oncologist is as follows:  Physician one is a 
radiation oncologist specialized in neuro-oncology with ten years of clinical practice in 
radiation oncology and involvement with over 200 glioma brain tumor cases, including 
multi-center clinical trials for brain tumor treatment (4,33).  Physicians two and three are 
radiation oncologists with less specialization in brain tumors, but each with more than 
twenty years of experience in radiation oncology.   
The reconstructed and registered MR images were used to define the GTV using 
the CMS Focal Ease software.  The guidelines for contouring required the definition of 
the GTV (enhancing tumor) from which the clinical (CTV) and planning (PTV) target 
volumes would be expanded.  The GTV was defined by the Gd contrast enhancement in 
T1 images or changes in the white matter (edema as defined by T2 MRI images).  Each 
radiation oncologist performed three different GTV outlines on each image set for each 
of the 11 patients, resulting in a total of 33 contours.  The three different outlining 
sessions for each physician were separated by approximately one month to prevent 
memory bias.  The laptop computer was brought to each radiation oncologist’s location 
of choice.  The time each of the radiation oncologists took for the outlining process was 
measured and recorded as part of this study.   
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II.6.  Analysis of contouring variability 
 
All analytical analysis and image data transformation was performed using 
programs developed with Interactive Data Language software version 5.4 (IDL, 
Research Systems Inc, Boulder, Colorado). 
II.6.a.  Intra- operator variability 
The intra-operator variability was calculated by overlapping the three volumes 
defined on the same patient by the same radiation oncologist at roughly one-month 
intervals.  The variability was then calculated as the ratio of the average disagreement, 
that is, the size of each volume minus the intersection of the three volumes, divided by 
the average size of the three volumes (see Appendix A).  For example, if a radiation 
oncologist had identified the same target volume in the three sets of contours prepared 
for any single patient, then the variability for that patient would have been zero.  The 
larger the difference between contours of the same physician, the larger this value 
becomes. 
II.6.b.  Inter-operator variability    
The inter-operator variability was calculated using the nine sets of outlines for 
each of the eleven patients and then calculating the disagreement of each volume outline 
prepared by each physician for each patient with each volume outline prepared by each 
of the other two physicians for that same patient.  This process was repeated for each 
patient to provide a data set comprised of the average disagreement between the three 
contours for each patient prepared by one physician with the other six sets of contours 
prepared by the other two physicians for that same patient (see details of calculation in 
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Appendix B).  The greater the difference between the contours of different physicians, 
the larger this ratio becomes. 
20 
II.7.  Results 
II.7.a.  Image registration 
The CT and MRI images were registered using the automatic registration 
function of the software.  The radiation oncologist specializing in neuro-oncology 
reviewed each case and, if necessary, performed an additional manual adjustment.  In all 
cases a good visual match was achieved in the axial, coronal and sagittal views.  This 
was confirmed by calculating the average 3D error over the eleven patients for three 
distinct anatomical landmarks.  An average displacement of 1.5mm ± 1.5mm was found.   
The maximum individual displacement was out-of-image slice plane where resolution 
accuracy could not exceed the minimum CT slice spacing of 4 mm.  These results are 
similar to previously reported image registration results (6,31).   
II.7.b.  Operator time 
The time each radiation oncologist took to outline all eleven patients was 
recorded.  It ranged from 4.0 to 6.5 hours in the aggregate, i.e., an average of 
approximately 30 minutes per patient.   Physician one spent the most time outlining the 
patient contours resulting in an average of approximately 30 minutes while physician 
two spent the least time, averaging approximately 20 minutes per patient.   
II.7.c.  Manual outline variability 
Reproducibility of the delineation of the GTV on the MRI scans by the same 
radiation oncologist (intra-operator variability) was assessed producing the results set 
forth in Figure 3 and Table 2.   
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Figure 3. 
Physician intra-operator variability 
 
Graph shows percentage of average physician intra-operator variability as a function of 
patient number for each physician.  Information on MRI type (pre- or post- surgery) and 
the average tumor volume (cm3) is included below each patient number. 
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Table 2. 
Physician intra-operator variability in percentages of total volume 
 
    Intra-
operator 
variability 
 
Physician 1 
 
Physician 2 
 
 Physician 3 
      
   Average 
 
   
Volume 
   (cm3) 
 
Average  
 
 
13 ± 5 
 
26 ± 19 
 
22 ± 23 
 
20 ± 16 
 
63 ± 33 
 
Median 
 
 
13 
 
22 
 
15 
 
16 
 
61 
 
 
The intra-operator variability averaged 20% ± 16% over all 33 contour sets of the 
eleven patients.  From Figure 3 it can be noted that the average of the reproducibility of 
the delineation of target volume was better in pre-operative cases (eighteen sets of 
contours: 15%) than in post-operative cases (fifteen sets of contours:  27%).   
The difference among GTVs identified by the three radiation oncologists (inter-
operator variability) was also assessed resulting in a total average of 28% ± 12% (Table 
3 and Figure 4).  The variability in the six pre-operative cases was 24% with a higher 
average ratio obtained for the post-operative cases, i.e., 32%. 
 
Table 3. 
Physician inter-operator variability in percentages of total volume 
 
    Inter-
operator 
variability 
 
Physician 1-2 
 
Physician 1-3 
 
Physician 2-3
 
Average 
 
Volume 
(cm3) 
 
Average  
 
 
30 ± 11 
 
23 ± 11 
 
30 ± 14 
 
28 ± 12 
 
63 ± 33 
 
Median 
 
 
26 
 
21 
 
27 
 
23 
 
61 
 
23 
 
 
Pre
28
Pre
90
Pre
98
Pre
40
Post
73
Post
108
Pre
100
Post
63
Pre
36
Post
17
Post
39
Patient #
MRI type
Av.Volume
(cm3)
%
0
10
20
30
40
50
60
70
80
90
100
1 2 3 4 5 6 7 8 9 10 11
Physician 1-2
Physician 1-3
Physician 2-3
 
 
Figure 4. 
Physician inter-operator variability 
 
Graph shows percentage of average physician inter-operator variability as a function of 
patient number for each physician.  Information on MRI type (pre- or post- surgery) and 
the average tumor volume (cm3) is included below each patient number. 
 
 
 
 It should be noted that one out of the eleven patients (i.e., patient 6) had a tumor 
which proved abnormally difficult to contour and represented a case of total resection.  
From Figure 3 and 4, a large variation can be observed for this patient.  The MRI used 
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was post-operative and the enhancement boundaries were not clear due to cystic 
formation inside the resected area.  This case was kept in the study since it represents 
cases encountered in the clinic and will serve to test if segmentations could have any 
potential for contouring all types of brain tumors treated with radiation therapy.  Notice 
from the variability analysis than even though there was a large variation for Patient 6, 
the median is close to the average and is within the standard deviation for both intra- and 
inter- operator variability (see Tables 2 and 3). 
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II.8.  Discussion 
In this section of the study it was found that the radiation oncologist who took the 
most time for outlining achieved the smallest intra-operator variability, i.e. 13% (the 
average for all of the oncologists was 20%), and the one who took the least time in 
outlining produced the largest intra-operator variability, 26%.   
  The variation between different radiation oncologists, or the inter-operator 
variability, ranged from 11% to 69% with an average variability rate of 28%.  These 
results mirror previously published results (12,6,13) and show that there is significant 
uncertainty in target volumes definition even when such volumes are determined by a 
single radiation oncologist observing the same set of data on multiple occasions.  The 
variability in delineation of GTV was about 10% larger in post-operative cases than in 
pre-operative cases.  In post-operative cases, the margins of residual tumor are unclear 
making the identification of the GTV a difficult task.  Previous studies confirm similar 
results (6,12).   
 The presented results confirm published findings that variability in tumor 
contouring by human experts is high.  Ten Haken and coworkers ran a simple test to 
assess the variation in the definition of contours by a team of physicians (neuro-
radiologist and radiation oncologist) when defining tumor volume in CT, MRI, and MRI-
CT registered images for 15 patients.  It was found that after two iterations of the 
contouring, the definition of tumor volumes were smaller and averaged just 75% of 
average volumes indicated in the first set of contours (22).  This difference was obtained 
by comparing the second set of volumes to the first set of volumes.  Notice that only two 
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contouring iterations were used to quantify the intra-operator variability, compared to 
three used in this study.  Yamamoto and coworkers measured intra- and inter-operator 
GTV brain contouring variability that averaged 8% and 15%, respectively  (12).  These 
outlines were performed by four radiation oncologists on  nine (pre- and post- surgery) 
brain CT images.  Their study goal was to assess the error in radiation field definition 
based on the target reconstruction.  Therefore, the intra-operator variability was obtained 
by comparing the smallest rectangular field that encompassed the two physician outlines.  
Similar to the previous study, only two iterations were considered to quantify the intra-
operator variability.  Using the same evaluation mechanism, the target inter-operator 
variability was obtained by the ratio of the rectangular projection surrounding a single 
physician contour divided by the  smallest rectangular field surrounding the projection of 
the intersection of all the physician contours.  This approach would underestimate the 
actual error in contouring since it doesn’t consider the outlining, but its rectangular 
enclosure.  Nevertheless, it showed the implications of contour variability in the 
definition of radiation treatment fields.   
A recent study reported very large inter-observer variations in brain GTV 
delineation for nine physicians of different specialties (radiation oncologist, neurosurgeon 
and radiologist) performing contours in both CT alone and CT with MRI for five patients 
(13).   The variability in their study was obtained from the standard deviation based on the 
mean of the volumes delineated by different observers.  This approach  is similar to the 
variability method of this study.  Their results found that the volumes varied between ± 
30% of the mean volume.  This contouring error is larger than the set-up variations and 
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organ motions that are traditionally taken into account in radiation therapy planning.  All 
of these results demonstrate the need for a method of tumor volume outlining that is more 
consistently reproducible.   
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CHAPTER III 
 
AUTOMATIC RADIATION VOLUME OUTLINES USING  
MRI SEGMENTATION METHODS 
 
III.1.  Introduction:  contouring with MRI automatic segmentation methods 
As previously noted, one of the critical factors to influence the success of 
radiation therapy three-dimensional treatment planning is the accurate determination of 
the target volume.  The current practice involves the manual contouring of the treatment 
area by radiation oncologists.  This manual method of separating image data is operator-
dependent, relies heavily on human judgment, and is very time consuming.  As shown in 
the preceding chapter, it is virtually impossible for different radiation oncologists to 
reproduce consistent tumor volume results using this methodology, despite accurate 
image registration (11,12).    
 Average inter-operator variability in outlining gross tumor volume (GTV) by 
radiation oncologists was found to be 28% ± 12% (see Chapter II).  Similarly, various 
studies have found contouring variation between different physicians of up to 32% 
(22,12,13).  The incorporation of automatic segmentation methods to determine the target 
volume could reduce this inherent variability in contouring.  This would aid in multi-
center treatment trials since it would prevent physician- and center- bias from affecting 
trial outcomes. 
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 Various supervised and unsupervised MRI segmentation methods for brain tumor 
volume definition have been developed and tested for various clinical applications, 
including the measurement of brain tumor volume changes during radiation therapy (21,18).  
These methods have not been applied in the delineation of tumor volume for radiation 
therapy treatment planning.  The objective of this chapter is to present the application of 
two MRI segmentation techniques, k-nearest neighbor (kNN) and Knowledge Guided 
(KG), in delineating brain tumor volume for use in radiation therapy treatment planning.  
The specific goals are to find the level of agreement of the segmentation methods with 
respect to the outlines developed by the radiation oncologists and to identify 
shortcomings and recommend improvements necessary to reach the goal of fully 
automatic GTV determination for radiation therapy. 
  This chapter is divided into six sections.  Section III.2 presents the basic 
principles for the MRI segmentation methods under study.  Section III.3 describes the 
steps followed to apply the MRI segmentation methods to radiation therapy treatment 
planning, including the development of custom software programs and algorithms.  These 
custom applications included:  extraction of volumes of interest, manipulation of image 
data and segmentation results to match treatment planning image coordinate system, 
extraction of contour points, and file formatting to adapt results of segmentation to the 
treatment planning software.  Section III.4 describes the methodology used to calculate 
the accuracy of the segmentation methods in delineating GTV for use in radiation 
treatment planning.  Since it is customary for radiation oncologists to delineate the GTV 
used in radiation therapy, all comparisons were performed against the physician outlines 
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presented in Chapter II.   Due to the variation in physician contouring encountered, a 
novel, probabilistic measurement of accuracy was introduced for this evaluation.  Section 
III.5 presents graphical and analytical results of the contours produced by the automated 
segmentation methods as compared with those generated by the physicians.  True-
positive and false-positive ratios for the computer segmentations were obtained and 
compared to those found for the radiation oncologists.  Section III.6 discusses the results 
obtained from this analysis and gives the conclusions on the application of segmentation 
methods for contouring in radiation therapy.  Additionally, information is presented on 
the necessary modifications to these computer techniques to be applied in clinical 
practice. 
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III.2.  Principles of MRI segmentation methods 
Each square on an image matrix is called a pixel.  The goal of segmentation 
methods is to group pixels into specific tissue regions or classes.  There have been 
various algorithms or classifiers developed to identify and separate different brain 
anatomic structures from MRI images (15,34).  Segmentation methods can be termed as 
supervised or unsupervised.  Supervised methods require an operator to select regions of 
interest (ROIs) on each slice of image data, which are then used to train the classifier.   
One of these methods is the “k nearest neighbor” (kNN) approach.  Unsupervised 
segmentation methods are classifiers that do no require the use of training data, such as 
the “knowledge guided” (KG) algorithm.   
Both of these methods use the information derived from several magnetic 
resonance contrasts (i.e. multispectral data).  This higher dimensional feature space 
improves discrimination for tissues with similar relaxation times and improves the image 
segmentation.   
 III.2.a.  kNN segmentation method 
The kNN is a supervised segmentation method that uses operator selected training 
data to identify each tissue type.  It requires the labeling of a certain number of pixels in 
each slice of multi-spectral MRI.  The kNN algorithm starts a pixel classification by 
finding the k labeled pixels from the ROIs closest to that pixel.  It then classifies it into 
the same class as the majority of the k-closest training data.  The kNN method uses 
pattern recognition for tissue classification, i.e. resolves the signal magnitude distribution 
as displayed in the different MR images into a probability map of tissue types (35).  It is 
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considered a nonparametric classifier because it makes no underlying assumption about 
the statistical structure of the data (34).   
Previous studies have shown that the success of supervised segmentation methods 
depends on the classifier and the training data.  The kNN method performed better than 
other tested supervised methods and has been used by many researchers for MRI 
segmentation (15,18).  Results from these studies indicate that relative measurements of 
tissue volume are feasible by independent segmentation of serial MRI data sets to within 
a maximum error of ± 6% for the kNN method.  Additionally, the intra- and inter- 
operator variation arising from the training data selection was found to be 6% and 4%, 
respectively (17). 
III.2.b.  KG segmentation method 
The kNN method discussed above is strictly based on pattern recognition in 
feature space. To fully automate the tumor volume determination, Clark, Hall and 
Goldgof encoded knowledge of the pixel intensity and spatial relationships in the images 
to create a fully-automated segmentation system known as the Knowledge Guided (KG) 
method (19,20).  First, the KG expert system was trained to identify slices of MR images of 
the brain that contain pathology from slices that do not contain pathology (19). This work 
was successfully extended to provide volume measurements of normal white matter and 
gray matter.  The KG system’s current incarnation is able to identify glioma tumor tissue 
after gadolinium enhancement in the brain (20).    
The KG system has five steps to perform the segmentation process (see Figure 5):  
(a) detect abnormal slices (i.e. containing tumor) by finding deviations from expected 
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normal properties within the slice; slices free of abnormalities are not processed any 
further; (b) extract the intracranial region from the rest of the MR image based on 
information provided in the first step; (c) initial tumor segmentation produced by a 
combination of adaptive histogram thresholds in the T1 and PD feature images, (d) 
removal of non-tumor pixels by a density screening operation on the basis that pixels of 
normal tissues are grouped more closely together in feature space than tumor pixels; and 
(e) complete tumor segmentation by analyzing each spatially disjoint region in image 
space separately, removing regions free of tumor and those regions remaining labeled as 
tumor (20). 
III.2.c. MRI non-uniformity correction 
Many contributions to the literature on MRI segmentation have stressed an artifact of 
magnetic resonance imaging that the intensity of image pixels not only depends on the 
tissue type, but also on the location in the image, or rather in the radio-frequency (RF) 
antenna (coil).  Several methods have been described to correct for the resulting image 
nonuniformity, mostly based on separation of low-frequency information in the image 
through smoothing or filtering.   A recent study has shown that these corrections do not 
separate the nonuniformity from the image information (36).  More importantly, it was 
found that although correction techniques have a significant effect on pixel intensities, 
the effect on brain segmentation results is non-significant. The tumor segmentation 
methods considered in this research are robust for RF nonuniformity effects since brain 
tumors are confined to small volumes and intensity nonuniformy is a slowly varying 
function of location. 
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Figure 5. 
KG automated segmentation process  
Reprinted with permission by IEEE Transactions on Medical Imaging (20). 
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III.3.  Application of MRI segmentation methods to radiation oncology 
 
III.3.a.  Segmentation methods 
The kNN segmentation method was run on UNIX workstations (Sun 
Microsystems, Mountain View, CA) and the KG system was run on a SPARCstation 
Ultra 20 computer (Sun Microsystems, Mountain View, CA).   Both systems were  
purchased around 1996.  A network and software environment was used in which MRI, 
CT, Focus treatment planning systems, the laptop computer and the image processing lab 
were all integrated to allow for convenient flow of images and other data between 
platforms.   
The kNN segmentation method requires the user to select training data from each 
MRI slice.  Since research has already been done on the variation arising from data 
selection by multiple users, this variable was not further evaluated in this study (17).  In 
the present study, the researcher, a certified medical physicist, selected the training data.  
The KG system requires no user input when performing the segmentation process to 
extract the tumor pixels.  
The results from the segmentations included scattered tumor-labeled pixels in 
addition to the main body of pixels identified as “the” tumor.  Consistent with the 
previously reported studies, pixels from the segmentation results that were clustered 
together were selected for tumor classification and the scattered individual pixels were 
discarded. 
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III.3.b.  Registration to CT coordinates system 
Final results from both MRI segmentation methods were transformed to the CT 
coordinate system using the transformation matrix produced by the Focal Fusion 
Registration software to allow comparison with the GTV outlines prepared by the 
radiation oncologists.  The use of the same transformation matrix for both physicians 
and segmentations eliminates any error arising from the image registration. 
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Figure 6. 
Contour extraction process 
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III.3.c.  Contour extraction process 
The results from the segmentation methods several pixels labeled as “tumor”.  A 
software toolkit was developed to extract contours from these results.  Various routines 
were developed to perform this contour extraction, some of which can be found in 
Appendix C.  The goal was to find a closed smooth contour that tightly enclosed all the 
tumor pixels from the segmentation, as presented in the previous figure.  Figure 6 
summarizes the different steps or programs used in obtaining automated tumor volume 
contours.  All programs were developed with Interactive Data Language software 
version 5.4 (IDL, Research Systems Inc, Boulder, Colorado).   
 
 
 
 
 
 
 
 
 
 
 
 
 
38 
III.4.  Accuracy of MRI automated segmentation methods 
The difference between brain GTV delineation for different physician specialties 
(radiation oncology, radiologists, neurosurgeons) has been reported by Weltens et al. (13).  
The goal of this chapter is to evaluate the segmentation methods as possible tools for 
delineating GTV for treatment planning of brain tumor volumes.  Since it is customary 
for radiation oncologists to delineate the GTV used in radiation therapy, the contours 
obtained from the physicians in Chapter II were used as the basis for comparison.  Due 
to variation in contouring, a probabilistic interpretation of the volumes delineated by the 
radiation oncologists provided the basis for comparing both the individual physician and 
the automated segmentation systems.   
Specifically, the probability that a pixel in an image is properly classified as part 
of the tumor volume was determined by the number of times that pixel was included in 
the nine outlines prepared by the three physicians.  Every pixel in the image volume was 
labeled with an integer value corresponding to the number of physician contours in 
which it was included, e.g., if a pixel was never included in any physician outline its 
corresponding value would be zero whereas a pixel included in every physician outline 
would have a value of nine.   The resulting composite physician GTV is comprised of 
pixels labeled with values from zero to nine that define the probability of finding tumor 
volume.   
The pixel label provided the weight for measuring accuracy.  This analysis was 
done on a pixel-by-pixel basis.  Thus, the loss of accuracy associated with a failure to 
classify a pixel as being part of a tumor volume would decrease in proportion to the 
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weight associated with that pixel.  For example, the failure to include a pixel that was 
assigned a label of 9, i.e. a pixel selected every time, would reduce accuracy more than 
missing a pixel that was assigned a label of one, i.e., a pixel selected only once by the 
physicians.   
Final accuracy for the computer segmentation is then defined as the ratio of the 
total sum of weights contained within the computer segmentation volume to the total 
weights generated from the nine volumes produced by the physicians (see Appendix B).  
This approach measures the level of agreement between the automated systems and the 
physicians on whether any given region of tissue should be characterized as part of the 
gross tumor volume, i.e., it provides the study’s true positive rate for the automated 
contouring systems.  The same protocol was used to determine the accuracy of each 
contoured volume produced by each individual physician.   
To estimate the false positive rate, i.e., the level of agreement between physicians 
on healthy tissue which was incorrectly characterized as constituting part of the GTV, 
the study calculated the excluded accuracy volume in an analogous manner (Appendix 
B).  All analytical analysis was performed using programs developed with Interactive 
Data Language software version 5.4. 
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III.5.  Results 
III.5.a.  Computer segmentation processing time 
The time to perform a kNN segmentation averaged 20 minutes per patient with 
some variation based upon the number of slices evidencing enhanced tumor and the 
difficulty of selecting the training data for the kNN segmentation algorithm.  For the KG 
system, the only time required was in the preparation of the MRI scans for segmentation.  
Specifically, in the case of the KG system, approximately 1.5 hours of operator time was 
required to prepare the necessary data for automatic segmentation.   
It should be noted that the data preparation task for the KG system could be 
substantially or fully automated in the future.  This would reduce the human operator 
time currently required by the segmentation system.  The process of automatic 
segmentation using the KG system required approximately thirty minutes of computer 
time on for all patients and required no user input.  Note that computers have increased 
in speed the last few years, which would result in faster processing times for the 
computer segmentation methods. 
III.5.b.  Contour extraction mechanism 
 The computer segmentations resulted in pixels from which contours were 
extracted following the technique described in Figure 6.  The following figure represents 
in detail the process of contour extraction mechanism. 
 
 
 
 
41 
(a) 
 
(b) 
 
(c) 
 
(d) 
 
 
Figure 7. 
Example of the contour extraction process 
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 Figure 7 shows the steps involved in the contour extraction process for an image 
of patient #3 using the kNN process.  The top (a) images show the segmentation results 
and resulting GTV outline.  This figure shows the segmentation case which resulted in 
“sections” of tumor labeled pixels.  It can clearly be noted that the resulting contour 
from the pure segmentation could not be used for radiation therapy because of the 
resulting multiple small contours instead of a single contour enclosing the pixels.  The 
second set of images (b) shows a polar coordinate system representation of that 
segmentation.  This section of the algorithm used the center of mass of the image pixels 
to calculate the distance of each boundary point.  This is represented as black dots in the 
figure.  For each radian angle section, the farthest point was found.  An interpolation was 
performed to obtain the missing radian angle points.  An averaging of the maximum 
radius value for each fraction of angles was obtained to smooth the contour.  The 
resulting contour in polar coordinates is displayed as a solid line in red.  The conversion 
to the image coordinate system of this contour is represented next to the polar figure.  
The third set of figures (c) show the resulting area labeled tumor as a result of filling the 
image with the polar coordinate process, followed by the contour extraction and the 
integration of the outline in the treatment planning image.  The last set of images (d) 
show one of the outlines for each physician (from left to right, Physician 1,2,3).  The 
automatic extraction of contour as the result of the software program created in this 
research resulted in a contour extraction that is comparable to the contours produced by 
the physicians.  Similar results were obtained for the KG process, which are 
demonstrated in Figure 8.   
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(a) Segmentation results 
 
(b) Contour extraction process 
 
 
(c) Contours from Physician 1, 2 and 3 
 
 
Figure 8. 
Example of KG contour extraction process 
 
Figure shows the steps for contour extraction process using KG for an image of patient 
#5.  (a) Top images show the segmentation results and resulting GTV outline, (b) second 
set of images show the results from filling the image with the polar coordinate system, 
extracting the contour and integrating the outline in the planning image, and (c) show 
one of the outlines from each physician (from left to right, Physician 1,2, and 3).  
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It can be observed from the previous figures that these routines also create a 
smoothing effect for the contours.  This result can be seen in more detail in Figure 9.  
This figure shows an example of a case where the tumor segmentation resulted in a 
continuous section of tumor pixel classification.  The application of the contour 
extraction routine served as a smoothing mechanism.  
 
 
Figure 9. 
Example of contour smoothing result 
 
Figure shows the smoothing effect resulting from implementing the subroutines for 
contour extraction.  First image (left) shows the result from the segmentation, continuing 
with the contour extraction, filling the image and final smoothed contour (image on 
right).  See Appendix C for details on the contour extraction algorithm. 
 
 
III.5.c.  Automated GTV contour results   
 For the automated segmentation methods it should be noted that the KG 
algorithm was not designed to evaluate non-enhancing tumors (tumors not visible on T1-
weighted MRI) such as those encountered in connection with Patients 1 and 2.  For 
Patients 3 and 6, the KG method identified tumors in very few of the slices that had 
physician outlines for tumor.  Patient 6 had cystic formation inside a partly enhanced 
area so the margins were not clear (see Figure 10).  The MRI used was post-operative 
and the enhancement boundaries were not clear due to cystic formation inside the 
resected area. 
45 
(a)     (b)
(c)     (d) 
 
Figure 10. 
GTV contours for patient 6  
 
MR image of patient 6 showing a GTV contour from physicians 1 (a), 2 (b), and 3 (c); 
and kNN segmentation (d).  Notice the variability between all physician GTV contours 
and close agreement of kNN segmentation with Physician 1.  The MR image shown is a 
T1 axial scan after application of Gd contrast. 
 
The kNN performed well for this difficult case involving a cystic formation inside 
a partly enhanced area since the user selects the training data.   Notice in Figure 10 that 
all three physicians contoured an area beyond the contrast enhancing area.  This is due to 
information from the previous image slice.   The kNN method misses additional tumor 
volume since it does not use 3D information, i.e. volume information from previous and 
following images.   
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 Patient 3 had dentures and implants that caused artifacts in the images, making 
the automatic segmentation difficult (Figure 11).  In this case, there was also cystic 
formation inside the enhanced area.  The kNN method was able to segment this contour 
and obtain results within the contours produced by the physicians.  The KG was unable 
to segment most of these slices.  
(a)    (b)
(c)     (d) 
Tumor
Artifact
kNN  
Figure 11. 
GTV contours for patient 3 
 
MR image of  patient 3 showing a small teeth artifact effect next to tumor containing Gd  
enhancement with non-enhancing cystic necrotic centers.  Contours shown are GTV 
contours of (a) physician 1, (b) physician 2, (c) physician 3, and (d) kNN segmentation.     
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(a) 
(b) 
(c) 
 
Figure 12. 
GTV contour series from physician 1, kNN and KG for patient 4 
 
Series of contours from physician 1 (a),  kNN (b) and KG (c) segmentation.  Notice the 
excellent results for the segmentation methods at the middle slices and the failure found 
at inferior slices.  
 
 
It was additionally found that the KG segmentation method performed poorly for sections 
of the tumor that were located in the lower part of the brain.  This was the case  for 
Patients 4 and 9 where the lower axial scans were not identified properly regardless of the 
enhancing property of the tumor.  For both of these patients, the KG missed the last slices 
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of the enhancing tumor.  This effect can be observed in Figure 12, which shows a series 
of lower brain axial slices spaced 4 mm.    Note also that the enhancement and tumor 
volume margins are not as clear in the lower slices.  Knowledge from previous slices is 
desirable to correctly identify tumor volume. 
III.5.d.  Accuracy 
As described in section 4 of this chapter, the results from the physicians were 
used as the basis for assessing the accuracy of the radiation oncologists and the MRI 
segmentation methods to determine GTV for brain radiation therapy brain.  It was 
previously noted that the same transformation matrix was used for comparing contours 
generated by the physicians and the segmentation methods therefore eliminating any 
errors arising from the image registration.   
The results of the accuracy calculation in percentages of total volume are 
tabulated in Table 4.  The kNN method gave an average accuracy of 59% for pre-
operative scans compared to the 52% average obtained for post-operative scans.   For the 
KG method three of the pre-operative cases were non-enhancing tumors or had cystic 
formation (i.e., Patients 1, 2, and 3) and were unable to be segmented, as discussed 
previously.  The average accuracy of the three physicians is 85% ± 7%, compared to 
56% ± 6% for the kNN method and 52% ± 7% for the KG method, resulting in a 
difference from the physicians’ contours of 29% and 33% for the kNN and KG method, 
respectively.  Comparing this difference with the average inter-operator variability of 
28% ± 12% for all eleven cases (with a range of variability between physicians from 17 
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percent to 60 percent (Figure 4), the automated segmentation methods are within the 
variability range of the physicians. 
 
Table 4. 
Accuracy of physicians and segmentation methods  
 
Patient 
# 
MRI 
 Type 
(+) 
Average 
Volume 
(cm3) 
Accuracy 
Physician 
1 
Accuracy 
Physician 
2 
Accuracy 
Physician 
3 
Accuracy 
kNN 
method 
Accuracy
KG 
method 
 
1 
 
Pre 
 
28 86 87 89 57 n/a 
2 Pre 90 92 82 94 67 n/a 
3 Pre 98 92 95 91 62 n/a 
4 Pre 40 86 92 89 58 48 
5 Post 108 86 90 91 62 50 
6 Post 73 71 63 57 52 n/a 
7 Pre 100 89 94 88 57 63 
8 Post 63 84 88 89 51 54 
9 Pre 36 74 91 78 52 43 
10 Post 17 79 87 88 48 60 
11 Post 39 91 89 86 46 48 
 
Average 
  
  63 ± 33  84 ± 7  87 ± 9 85 ± 10  56 ± 6  52 ± 7 
 
It is important to note that the design of this study defined “true” volume by using 
the GTV generated by the same three radiation oncologists to whom the automated 
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systems were compared; accordingly, it would not be possible within this conceptual 
framework for the accuracy of the automated systems to have exceeded that of their 
human counterparts.   This limitation of the study is explored further as part of Future 
Work in the Discussion Section, below.   
   
Table 5. review pacer for updated docket (0.3); review pleadings received and update 
files accordingly for attorney use (1.6); 
Excluded accuracy for physicians and segmentation methods 
 
Patient 
# 
MRI 
 Type(+) 
Physician
1   
Physician 
2 
Physician 
3 
kNN 
method 
KG 
method 
 
1 
 
Pre 8 20 15 7 n/a 
2 Pre 13 6 19 4 n/a 
3 Pre 5 18 4 2 n/a 
4 Pre 5 25 9 3 4 
5 Post 7 18 15 3 5 
6 Post 34 58 32 41 n/a 
7 Pre 6 23 7 1 4 
8 Post 8 19 17 7 14 
9 Pre 5 62 11 9 3 
10 Post 6 26 24 12 23 
11 Post 14 16 8 1 1 
 
Average 
 
10±9   26±17  15±8 8±11 8±8 
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III.5.e.  Excluded accuracy 
The accuracy measure we introduced favors larger volumes since there is no 
penalty in the measure for “false positive” pixels.  This false positive effect is expressed 
as a ratio based on the volume included by the computer segmentations and excluded by 
the physicians’ modeling volume; these results are set forth in Table 5.  All values 
shown are in percentages of total volume.  Interestingly, the false positive rate of the 
kNN method was 8% ± 11% and of the KG method was 8 ± 8 % while the false positive 
rate of the physicians was 17% ± 11%.  Thus, the automated segmentation methods have 
been shown to err on the side of underestimation of tumor volume when compared with 
the physicians.  
III.5.f.  Analysis of contour variances 
The two segmentation methods were assessed visually and quantitatively to 
evaluate where the major volume differences occurred between the contours delineated 
by the physicians and the automated systems.  This analysis should prove useful in 
suggesting further studies with larger sample sizes, which could significantly improve 
the accuracy of automated contouring systems for radiation oncology.  In general, the 
largest variations between the contouring of the physicians as a group and those 
produced by the automated systems were found at superior and inferior edges of tumor. 
This effect can be seen clearly in Figure 12, which shows enhancing tumor in the most 
inferior slice which was not identified properly by the kNN method and which the KG 
method completely failed to detect.  For slices in the central sections of tumors, both 
segmentation methods provided contours that were much closer to those created by 
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human experts.  Another example of this effects can be seen in Figure 13, which shows 
the three superior slices for Patient 9 and contours drawn by the physicians in the top 
slice which shows small tumor enhancement.   
 
 
(a)      (b)       (c) 
(d)    (e)        (f) 
 
Figure 13. 
Series of MR axial images for patient 9 
 
Images (a), (b), and (c) show the top three slices of tumor, 4 mm spaced.  Notice how 
image (c) does not show much enhancement, but by comparing to previous images, some 
tumor volume can be seen.  The tumor volume drawn the first time by each physician on 
the MR slice shown on (c) is displayed in images (d), (e) and (f) for physician 1, 2, and 3 
respectively.    
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The images (a) through (c) of Figure 13 demonstrate that the contour on image 
(c) was included by the radiation oncologists mainly due to the physicians’ knowledge 
that there is tumor in the previous slices at the corresponding locations.  Notice the 
variations in the contours between the physicians.  Interestingly for this specific case, 
one physician did not draw any GTV on a slice he had marked on first contouring as 
containing tumor the next two times he was faced with identical data.  The segmentation 
methods did not identify tumor volume on image (c).  The kNN segmentation program is 
currently limited to 2-D identification protocols, i.e. each individual slice is analyzed for 
tumor without considering adjacent slices.  The KG method, while taking information 
from prior slices forward, is essentially also based on 2-D analysis.  The drawing of 
contour edges by human experts is a very subtle and subjective activity blending 
scientific training with heuristics developed through experience with a variety of tumors 
contoured over many years.   
Figure 14 shows a 3-D reconstruction of the tumor volume drawn by physician 1 
(outer yellow volume) and the GTV estimated by the kNN (Figure 14a) and the KG 
(Figure 14b) systems.  It can be seen clearly that the physician volume contains the GTV 
contours produced by the segmentation methods and that the segmentation methods fail 
to identify tumor most frequently in the superior and inferior edges of a tumor.  The 
kNN and KG methods have a larger agreement with the physician towards the center of 
the tumor compared with the superior and inferior borders.  The physician volume  
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contains the segmented GTV.  It can be noticed that the segmentation methods under-
segment the GTV volume compared to the radiation oncologist.      
(a) 
 
 
(b) 
 
 
Figure 14. 
3D GTV volumes for physician 1, kNN and KG volumes for patient 11 
 
The 3D reconstructed images for patient 11 showing contours of physician 1 (outer 
yellow volume), kNN (inner red volume in figure 14a), and KG (inner red volume in 
figure 14b).   
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In addition to the differences found at the superior and inferior edges of the tumor 
volume, the contours prepared by the segmentation systems diverge from those of the 
human experts to an increasing degree the further from the center of a tumor the contour 
lines are compared.  For the areas where the oncologists agreed all the time (pixels 
labeled 7,8 or 9), towards the center of the tumor, the accuracy for kNN and KG was 75% 
and 72%, respectively.  Figure 15 represents the general effect encountered of decreasing 
agreement between the contours produced by the automatic segmentation methods and 
the physicians as compared from the center of the tumor towards its outside borders.  
Additionally, it demonstrates that computer segmentations tend to agree with the contours 
prepared by radiation oncologists when the radiation oncologists agree with each other. 
 
 
 
 
Figure 15. 
Axial contours for physicians 1,2,3, kNN, and KG segmentation 
 
Axial slice shows contouring of physicians 1, 2 and 3 (outer contours represented in red, 
orange and pink, respectively), and kNN segmentation (innermost contour represented in 
blue), and KG segmentation (inner contour represented in light blue).   
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Figure 16 shows a section of the Receiver Operating Characteristic (“ROC”) 
curves for all three physicians compared with those for the kNN and KG systems.  The 
ROC curve is a plot of the true positive rate (TP) against the false positive rate (FP). It 
shows the tradeoff between sensitivity (portion of accurate TP) and specificity (portion 
of accurate true negative (TN)) since any increase in sensitivity will be accompanied by 
a decrease in specificity.  The closer a curve follows the left-hand border and top border 
of the ROC space, the more accurate the test.   
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Figure 16. 
ROC curves for all three physicians compared with kNN and KG   
 
 
 
 
 
57 
True tumor (TP) for this study is based on the times a pixel was included in an 
outline by the physicians.  The curves for the segmentation methods must necessarily be 
below those of the physicians since the latter defined “truth” for purposes of this study.  
It can be seen that automated segmentation systems tend to fail in sensitivity but have a 
high degree of specificity, that is, most pixels identified are within the volume of the 
tumor defined by the physicians.  This is also evidenced by the data summarized in 
Tables 4 and 5, and Figure 15. 
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III.6.  Discussion 
The purpose of this study was to evaluate KG and kNN as potential “cyber 
colleagues” for radiation oncologists in determining tumor volume definition for 
treatment planning.  A probabilistic measure of accuracy was proposed accounting for 
the inherent variability in operator judgment.  It was found in the previous chapter the 
average intra- and inter- operator variability in outlining by radiation oncologists to be 
20% ± 16% and 28% ± 12%, respectively.  The underlying ranges of data displayed a 
high level of variability, a range of  8% to 91% and 11% to 69% for the intra- and inter-
operator variability, respectively.  The average accuracy of the kNN segmentation 
method was found to be 56%±6% for all 11 cases while the KG method yielded 
accuracy of 52% ± 7% for the seven cases compared with the physician contours.  Based 
on the range of variability found for the physicians, it is clear that both segmentation 
methods performed within the variability of the outlining by radiation oncologists.  Even 
without any of the system enhancements suggested herein, the automated segmentation 
methods could qualify as independent experts since they perform within the large range 
of inter-operator variability found among radiation oncologists.  Combining the 
information obtained from the segmentation methods could help radiation oncologists, 
especially those with limited experience, identify the target volume with greater 
accuracy. 
The variability in physician delineation of GTV was found to be about 10% larger 
in post-operative cases than in pre-operative cases (Chapter II).  Similarly, a larger 
variation was found for post-operative cases using the automatic segmentation methods.  
59 
In post-operative cases, the margins of residual tumor are unclear making the 
identification of the GTV a difficult task for both physicians and automated segmentation 
systems.    
The segmentation methods were less accurate at the superior and inferior edges 
of the tumor volume compared to the middle sections.  A greater difference was found, 
at least in part, from the small enhancement found at the edges of the tumor.  The 
drawing of contour edges is very subtle and subjective.  The radiation oncologists use a 
3-D method of contouring, that is, one in which the previous and subsequent 2-D slices 
are used to predict the presence of tumor volume on the slide in question.  This 
knowledge needs to be included in the segmentation methods to improve accuracy, i.e., a 
3-D segmentation method is needed, which uses knowledge and pixel information of 
tumor from adjacent 2-D slices.  While the KG method has such encoding, the subtleties 
of partial volume effects at the edges are currently problematic. 
Compared to the kNN method, the KG method performed poorly for glioma cases 
that show Gd enhancement with non-enhancing cystic necrotic centers.  The margins of 
the tumor are not clear for these cases and even the physicians’ contours show a larger 
intra- and inter-operator variability for these cases.  A possible solution is to use more 
knowledge from the T2 MRI images in the automatic segmentation process.  
Additionally, the KG method failed to detect tumor volume located in the lower part of 
the brain.  The KG system performs differently in different areas of the brain because it 
has rules describing the anatomy at the various levels through the brain.  Anatomical 
structures are simpler in superior areas of the brain and increase in complexity towards 
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inferior sections.  The kNN method was able to give better results to these cases since 
there is some user input selecting the initial tumor pixels and slices from which the kNN 
method began its segmentation analysis. 
Two cases that showed non-enhancing tumor volumes were not segmented by the 
KG method.  It is necessary to incorporate automatic segmentation of non-enhancing 
brain tumors in the knowledge guided technique.  Some work has been performed in 
developing an automatic method that separates non-enhancing brain tumors from healthy 
tissues in MRI images showing promising results (37).   
In summary, there is need for more work on the KG method to make it fully 
compatible for use in radiation therapy; this work would include modifications to permit 
contouring of partially enhancing tumors, resection cavities and non-enhancing tumors.  
The user guided kNN method performed better under these special circumstances due to 
its use of user input for initial selection of training pixel data.   
Future work should concentrate on optimizing the segmentation techniques to 
improve the accuracy of their results, especially with respect to the definition of the 
inferior and superior borders of the tumor volume.  Note that different glioma types were 
included in this research to generate the basis of possible future applications of brain 
segmentation methods.  It would be of interest to perform more in-depth analysis on the 
variability of segmentation methods based on the type of brain tumors by selecting a 
specific type of tumor patients (glioblastoma, astrocytoma or oligodendrogliomas) and 
study its tumor specific segmentations results.  Both segmentation methods considered 
herein should also be enhanced to allow them to identify edema and structures at risk.  
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This would permit future incarnations of these automated systems to provide outlines for 
such structures and to assist physicians in automatic detection of normal tissues.   
Additional research should also be performed which analyzes the results of the 
automated segmentation methods in a way that does not favor the physicians involved in 
the comparison.  It was previously noted that the contours from the radiation oncologists 
used for comparison were also used to define the “true” volume.  This posed a limitation 
in that the accuracy of the computer segmentation methods would always fall below that 
of the physicians.  A recent study recommends cooperation with a radiologist and/or 
neurosurgeon to reduce the variability in tumor volume definition (13).  Incorporating a 
second group of physicians (preferably radiation oncologists, neurosurgeons and 
radiologists) as experts working together to define “true” gross tumor volume based on 
their mutual consensus would allow subsequent studies to fairly compare the accuracy of 
automated segmentation systems with that of radiation oncologists evaluating the same 
data. 
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CHAPTER IV 
 
EFFECT OF SEGMENTATION METHODS  
ON RADIATION THERAPY TREATMENT PLANS 
IV.1. Introduction:  automatic segmentation and radiation therapy 
The aim of three-dimensional conformal radiation therapy (3D-CRT) is to give a 
high dose of radiation to a carefully delineated target volume, i.e., to the tumor, while 
minimizing the dose received by the adjacent healthy tissues.  This is feasible only if the 
region of interest (i.e., the target volume) can be clearly differentiated from the 
surrounding healthy tissue (9).  The patterns discernable from failed treatment protocols 
for brain gliomas utilizing high-dose 3D-CRT have shown that over 89% of tumor 
recurrences were located within the primary tumor bed (5,6,8).  Escalating the dose to this 
viable tumor area might increase survival rates for such cases by reducing the incidence 
of local tumor recurrence.  The rationale for such dose escalations in 3D-CRT brain 
tumor treatment relates to the dual goal of simultaneously sparing normal brain tissue 
while delivering high target volume doses of radiation.  Accordingly, the success rates 
achieved through high quality radiation treatments can be increased through more precise 
tumor localization.  The goal of implementing automatic tumor segmentation methods in 
radiation therapy planning is to accurately determine the target area to allow dose 
escalation if necessary  and to reduce the amount of physician time required to create 
superior treatment plans. 
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It was previously found that the kNN and KG computer segmentation methods 
under-segment the tumor volume when compared with the weighted average of outlines 
produced by radiation oncologist but are within the variability of the contouring 
performed by experienced radiation oncologists based on the same data (see Chapter III).  
Additionally, the automated segmentation methods show a large degree of both 
specificity and accuracy in identifying central areas of the GTV.   
The general aim of this chapter is to study the results of applying the two 
automated MRI segmentation techniques, kNN and KG, to the creation of radiation 
therapy treatment plans.  The first step in this process was to integrate the knowledge 
obtained from the previous chapter to modify the GTV generated by the automated 
segmentation methods.  Following this modification, a margin was applied to create a 
planning target volume (PTV).  The PTV in radiation oncology results from the 
application of a margin to the GTV to account for patient motion and variations in daily 
treatment setup.  This volume served as the basis for the creation of treatment plans for 
the contours produced by the automated segmentation methods.   
The evaluation of the resulting treatment plans was performed starting from the 
following hypothesis:  Radiation treatment plans developed from computer 
segmentations that are modified with a vertical extension are comparable in accuracy to 
the plans developed from physician contours.  This hypothesis was tested by comparing 
hypothetical radiation therapy treatment plans based on volumes generated by computer 
segmentation methods to the plans generated using volumes produced by experienced 
radiation oncologists. 
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This chapter is divided into eleven sections.  Sections IV.2 and IV.3 outline 
common concepts in the practice of radiation oncology, specifically brain radiation 
treatment.  Section IV.4 describes the brain radiation technique that was used to actually 
treat the patients whose data underlies this study.  Section IV.5 defines the methodology 
used herein to create hypothetical treatment plans for physician and the respective 
automated segmentation methodologies.  This section also explores the application of 
insights gained in the previous chapter to modify the GTV resulting from the 
segmentation methods for application in radiation therapy treatment planning.  Section 
IV.6 provides information regarding the selection of an expert physician to be used as the 
basis for comparison to test the above hypothesis.  Sections IV.7 and IV.8 explore the 
different treatment evaluation techniques used to validate the foregoing hypothesis.  They 
also introduce a unique evaluation scheme developed in connection with this study to 
evaluate the performance of any automated segmentation methods in radiation therapy 
planning.  Section IV.9 evaluates the methods used to test the accuracy of incorporating 
automatic segmentation methods for radiation treatment planning by using existing post-
treatment MR patient images.  The results from the original patient treatment were 
compared with the hypothetical treatment plans based on physicians and segmentation 
methods.  An evaluation technique that could be applied to any imaging modality was 
developed to perform this comparison.  The results are presented and evaluated in 
Sections IV.10 and IV.11. 
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IV.2.  Radiation treatment procedure 
The field of radiation therapy is diverse and complex.  This section is intended to 
familiarize the non-specialist reader with sufficient elementary information pertaining to 
radiation therapy to permit understanding of the design and results of this study.  The 
references cited herein may be consulted for more in-depth knowledge on various aspects 
of the study. 
The principal application of radiation therapy is the use of radiation to treat 
cancer.  Radiation, if carefully controlled, can cure or control cancer by inhibiting the 
cancer cells from dividing or reproducing, thus achieving tumor control.  The primary 
goal of radiation therapy is to produce the greatest possible control of the tumor while 
minimizing to the greatest extent possible all undesired side effects.  Early research 
established that different organs and tissues react differently to irradiation.  The radiation 
dose that should be directed toward the defined target is determined after considering 
several factors.  Important factors include whether the treatment is to be curative (return 
the patient to health) or palliative (reduce disease discomfort, increase patient’s quality of 
life), the tumor’s location, the tumor’s histology, and the risk of side effects from 
exposure to radiation.  Radiosensitivity of organs near the tumor is also of major 
importance since it determines how much radiation can be safely delivered to the area (38).  
For example, brain irradiation is limited when giving dose to areas close to the optical 
structures (such as optic chiasm, optic nerve, or eye lens).  These structures can be 
damaged if irradiated to the total radiation doses used to treat gliomas. 
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Radiation therapy works best when radiation is administered through relatively 
small doses delivered over the course of several sessions.  In this way, it can kill the 
tumor cells and yet allow sufficient time for the normal healthy cells around the tumor to 
repair any damage caused by the radiation.  A typical course of radiation treatment lasts 
from two to eight weeks, depending on the total dose of radiation to be delivered.  The 
treatment dose is defined in unit of “Gray” (Gy), which represent the amount of energy (1 
Joule) absorbed per kilogram of tissue.  For example, a regular CT exam delivers 
approximately 0.02 Gy.  The radiation dose administered during a typical course of brain 
treatment ranges from 45 to 60 Gy with daily doses ranging from 1.8 to 2.0 Gy.   
Radiotherapy for the brain is most commonly administered in the form of x-rays 
generated by linear accelerators.  These machines are designed to produce different x-ray 
energies (between 6 and 22 MV) for use in cancer treatment.  Different angles of 
treatments can be achieved by rotating the machine stand or “gantry”.  Linear 
accelerators produce radiation that exits outside a  “collimator” (see Figure 17).  The 
collimator system is designed to vary the shape of the beam by using two pairs of heavy 
metal blocks that can be moved independently to produce a rectangle-shaped radiation 
field or “field size.”  The rectangular treatment area can be further modified with the use 
of “blocks” or “multi-leaf collimators”.  Blocks or MLCs are used to cover up normal 
tissues inside the treatment field size to insure that radiation is being delivered principally 
to the tumor area.  Additionally, special filters may be placed in the path of the radiation 
beam to modify its dose distribution.  The most commonly used device is the “wedge”, 
which is a wedge-shaped absorber that causes a progressive decrease in the intensity of 
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the radiation beam (39).  This modifier is used to create dose uniformity over slanting 
target surfaces. 
LINEAR ACCELRATOR
collimator
jaws
MLC
gantry
treatment
couch
COLLIMATOR
MLC
RADIATION FIELD
 
 
Figure 17. 
Linear accelerator, collimator and field size with multi-leaf collimator 
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During the initial patient consultation the radiation oncologist determines the area 
of treatment by using diagnostic images, such as x-rays, CT, or MRI.  Prior to the 
widespread availability of x-ray computerized tomography (CT), whole-brain radiation 
therapy (RT) was routinely used to treat brain tumors, since conventional imaging 
techniques were unable to accurately assess the extent of tumor (5).  Three-dimensional 
(3D) treatment planning evolved through technological advancement in computers that 
allowed for improved target modeling in three-dimensions.  Three-dimensional (3D) 
conformal radiation treatment (3D-CRT) planning and delivery seeks to conform the 
shape of a prescribed dose volume to the shape of a 3-dimensional planning target 
volume (PTV) while simultaneously limiting the radiation dose to normal tissues.  3D-
CRT achieves this goal through the use of an external beam radiation therapy modality.  
Radiation treatment planning involves the use of highly specialized software and 
computers in designing the various treatment beams and shields to precisely localize and 
focus the radiation administered to the tumor.  All such treatment planning systems have 
to be approved by the Food and Drug Administration (FDA) prior to their use in a clinical 
setting.  Modern treatment planning systems are capable of preparing a patient treatment 
using a 3-D model of the patient, reconstructed from CT information (14).   
The treatment procedure for a patient undergoing 3D brain radiation therapy 
treatment is demonstrated in Figure 18.   The procedure typically commences with the 
definition of the treatment volume by a radiation oncologist.  A MRI together with a CT 
is used to outline the GTV brain volume by the radiation oncologist.  Additionally, the 
physician contours the organs at risk of receiving radiation (such as the optic chiasm and 
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brain stem), and other structures of interest.  A CT based radiographic volume in the 
treatment planning system provides the foundation for all contour definitions.  The 
treatment plans are designed and calculated by a “dosimetrist”.   
The dosimetrist selects the appropriate gantry angles, collimator angles, field size 
and field modifiers in order to ensure coverage of the target volume with the dose 
prescribed by the radiation oncologist.  Amongst the software tools that have been 
developed to aid in this process is the “beam’s eye view” display.  It consists of a 
projection of the patient anatomy as seen from the location of the radiation source.  From 
the beam’s eye view, it is possible to identify the best angles from which to irradiate the 
target and to avoid irradiating adjacent sensitive normal tissue (14).  Once the beam 
directions and field sizes have been selected, a block, or MLC aperture, is defined to 
protect normal tissues.  Several studies have identified the tolerance levels of various 
normal tissues to therapeutic irradiation (40,38).  These factors are considered when 
designing the aperture of the treatment beam.  Various treatment planning systems offer 
the ability to automatically design this aperture.  Once the ideal arrangement of treatment 
beams is directed to the patient, the radiation oncologist evaluates this plan to ensure that 
the dose coverage is adequate for the intended treatment.  This review is performed using 
the graphical display that shows the different lines of equal dose (“isodoses”) and the 
quantitative dose evaluation tools of the treatment planning software.  A simulation is 
then performed to verify the feasibility of the proposed treatment plan and to document 
the beam portals using radiographs.  Following a successful simulation, the patient starts 
the actual radiation treatment. 
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Figure 18. 
Description of a 3D radiation therapy process
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IV.3.  Radiation volume definition 
  In 3D-CRT treatment planning, the treatment volume is divided into various 
subsections.  These different volumes often have to be irradiated using different dose 
levels.  To avoid ambiguity in the definition of the target volumes, the International 
Commission on Radiation Units and Measurements (ICRU) created the ICRU 50 report 
that defines the different treatment volumes to be used for radiation treatment planning 
(41).   
  The palpable or visible extent of the tumor constitutes the Gross Tumor Volume 
(GTV).  As previously discussed in Chapter II, the radiation oncologist manually outlines 
this tumor volume.  In some cases, a margin is added around the GTV to include direct, 
local sub-clinical spread, i.e. an area that may not visibly show tumor but could contain 
cancerous cells.  This volume constitutes the Clinical Target Volume (CTV).  The 
delineation of the GTV and CTV are based purely on clinical considerations without 
regard to technical factors of treatment.  To obtain the final volume used in treatment 
planning, margins have to be increased around the GTV or CTV to account for variation 
in size and position of tissues relative to the treatment beams due to patient positioning, 
internal organ motion, and to variations in the daily treatment set up (see Figure 19).  
This volume is the Planning Target Volume (PTV).   In addition to the treatment 
volumes, normal critical structures, i.e. anatomical structures that can be damaged by a 
certain amount of radiation, must be defined in total to ensure that their radiation 
tolerances are not exceeded by the proposed treatment protocol (38).  
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 Figure 19. 
Illustration of volumes used in radiation therapy treatment planning  
 
(Adapted from ICRU Report 50 (41)) 
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IV.4.  Clinical brain radiation protocol 
  This dissertation is based on data from eleven brain cancer patients that were 
under the care of physicians at Moffitt Cancer Center.  This section describes the actual 
radiation treatment received by these patients.  Section 5, below, includes the description 
of the “virtual” treatments developed to estimate the efficacy of the computer 
segmentations (see Figure 1, Chapter I). 
  The eleven patients under consideration in this study underwent 3-D radiation 
treatment following surgery.  Since 3D-CRT has been used at Moffitt Cancer Center for 
more than 10 years, a certain consistency in target definition and planning has been 
developed and refined over this period.  The following figure summarizes the radiation 
treatment received by these patients.   
Brain surgery
Lateral Fields
PTV1
7-10 Fractions
12-20 Gy
3D-Conformal
PTV1
13-19 Fractions
26-34 Gy
3D-Conformal Boost
PTV2
5-8 Fractions
9-14 Gy
 
 
Figure 20. 
Brain clinical protocol 
 
  Radiotherapy for brain tumor patients usually begins within four weeks following 
brain surgery.  Radiation treatment was delivered with 6 MV or 15 MV photons from one 
of three Siemens linear accelerators (M6700, KD or Primus, Siemens Medical Systems, 
Malvern, PA).  One treatment of 1.8 Gy or 2.0 Gy was given daily, 5 days per week, for a 
total irradiation in the range of 54.0 – 60.0 Gy over six weeks.    The patients were 
initially treated for 7 to 10 fractions with opposed lateral fields of 6 MV and 15 MV to 
deliver a total dose in the range of 12.6-20 Gy to the initial planning volume (PTV1).  
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Subsequently, a 3D conformal plan was prepared with two to four fields conformed the 
PTV1.  A total treatment dose in the range of 45.0 – 46.8 Gy was delivered to the PTV1.  
Finally, a similar arrangement was used for the cone down treatment volume (PTV2) in 
the final 5 to 8 fractions to provide a dose in the range of 9.0 – 14.4 Gy.  This final dose 
is usually referred to as “boost” (see Table 6). 
 
 
Table 6. 
Treatment planning parameters for each of the patients 
 
 
Patient 
# 
PTV  
margins 
(cm) 
No. of 
boost 
fields  
Boost  
dose 
(Gy) 
No. of  
treatment 
fractions 
Total  
boost dose 
(Gy) 
Total  
treatment dose 
(Gy) 
 
1 
 
1.5 
 
3 
 
1.8 
 
7 
 
12.6 
 
59.4 
 
2 
 
1.0 
 
3 
 
1.8 
 
5 
 
9.0 
 
54.0 
 
3 
 
1.0 
 
4 
 
2.0 
 
7 
 
14.0 
 
60.0 
 
4 
 
2.0 
 
3 
 
2.0 
 
7 
 
14.0 
 
60.0 
 
5 
 
2.0 
 
3 
 
2.0 
 
7 
 
14.0 
 
60.0 
 
6 
 
2.0 
 
4 
 
2.0 
 
7 
 
14.0 
 
60.0 
 
7 
 
1.0 
 
4 
 
1.8 
 
8 
 
14.4 
 
59.4 
 
8 
 
2.0 
 
4 
 
2.0 
 
7 
 
14.0 
 
60.0 
 
9 
 
1.5 
 
2 
 
2.0 
 
7 
 
14.0 
 
60.0 
 
10 
 
2.0 
 
4 
 
1.8 
 
8 
 
14.4 
 
59.8 
 
11 
 
 
1.5 
 
 
4 
 
2.0 
 
 
7 
 
 
14.0 
 
 
60.0 
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A pre- or post- surgery MRI together with a CT scan were used by the radiation 
oncologist to identify the GTV volumes for the eleven patients in this study.  The GTV 
was manually outlined on the digital CT images with the aid of the hardcopy MRI.  The 
radiation oncologist defined the PTV from a margin around the CTV or GTV, following 
the recommendations in ICRU Report 50 (as discussed above).  The radiation oncologist 
decided upon the margin definition used to create the final PTV after considering actual 
tumor pathology, tumor location, and treatment protocol.  For the patient treatment, the 
PTV is defined and changed as appropriate throughout the course of treatment.  The 
initial Planning Target Volume (PTV1) for the first part of the radiation treatment (23-26 
treatment sessions or “fractions”) included the contrast-enhancing lesion (Gross Tumor 
Volume, GTV) and surrounding edema (CTV) demonstrated on the MRI plus a 1.0 cm to 
2.0 cm margin.  For the last 5 to 8 fractions, a cone down target volume (PTV2) was 
used, which included the GTV plus a 1.0 cm to 2.0 cm margin.  The cone down treatment 
(boost) aims at giving dose to the main tumor only, resulting in the GTV plus a margin 
(see Figure 21).   
Additionally, several structures of interest and organs at risk were outlined to aid 
in the definition of treatment fields and to limit the dose to critical organs.  The 
dosimetrists defined the skull, eyes, optic nerves, optic chiasm, brain stem, and normal 
brain volume for all of the patients in the study.  These contours were checked and 
approved by the radiation oncologist prior to finalizing the planning.  The dose received 
by these areas is documented and used for treatment planning decisions. 
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(a)
(b)
 
 
Figure 21. 
Description of initial and boost tumor volume delineation 
 
(a) Green (inner) contour:  initial tumor volume (CTV=GTV plus edema) and  
     Yellow (outer) contour:  PTV1 (initial CTV plus margin for treatment) 
(b) Blue (inner) contour:  cone down tumor volume (only GTV) and  
     White (outer) contour: PTV2 (final boost volume GTV plus margin) 
 
 The patient treatment plans were created on a FOCUS treatment planning system 
(Versions 2.4-2.5, Computerized Medical Systems, St. Louis, MO).  All PTV volumes 
were generated from the CTV or GTV using the 3D automatic margin growth function 
from the treatment planning system software.  Research has shown that the PTV can 
automatically be derived from manually drawn volumes to aid in the treatment planning 
process and to increase the reproducibility and accuracy of the treatment (42,43).  The use 
of automated volume expansion has been proven to be an invaluable aid for the final 
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estimation of the treatment volume by physicians.  Brain PTV for the patients was 
defined by entering the desired margin around the GTV.  The automatic growth was 
limited or stopped at the skull bone.  If necessary, the automatically generated PTV 
volume was trimmed manually by the radiation oncologist around critical structures such 
as the optic chiasm and optic nerves.   
The 3D radiation treatments were performed using static multiple, non-coplanar 6 
MV or 15 MV photon beams.  Beam modifiers, such as wedges, were used when 
necessary to create dose uniformity around the target (see Figure 22).  The beam field 
shaping was accomplished through a multileaf collimator (MLC) to block normal 
structures from the projection of the target in the beam’s eye-view.   
 
 
 
Figure 22. 
Representation of typical cone down 4-field arrangement for 3D-CRT 
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The planning process relied on the included beam’s eye view (BEV) facility to 
position and design each beam automatically.  Blocking was performed automatically 
using a standard 0.8 cm margin around the PTV.  Figure 23 shows the BEV projection of 
two treatment fields with standard MLC blocking that conforms to the planning target 
volume (solid volume displayed in red).  
 
 
 
Figure 23. 
Beam’s Eye View projection of two treatment fields 
 
79 
For some clinical cases, the blocking was manually modified such that critical 
structures would not receive doses beyond their radiation tolerance.  Several studies have 
identified the tolerance levels of various normal brain tissues to be within the range of 
30-55 Gy (40,38).  Based on these tolerances, the dose to at least one eye was limited to 50 
Gy if this could be accomplished without shielding the gross tumor volume.  The dose to 
the optic chiasm was limited to 54 Gy, except for cases where the gross tumor volume 
would be significantly under-dosed.  This was done to reduce any significant risk of 
visual problems arising from the radiation treatment.  In the cases under consideration, 
the optical structures were blocked at about 52 Gy.  Sometimes a portion of the planning 
target volume was intentionally under-dosed due to this additional blocking.   
 Three dimensional dose distributions were calculated with 0.45 cm resolution 
using the Clarkson algorithm and Convolution algorithm (algorithms implemented by 
CMS treatment planning software) on HP workstations (Hewlett Packard, Palo Alto, 
CA).  It is important to note that the dosimetric effects of tissue in-homogeneities were 
not taken into account for these plans in any of the brain dose distributions calculated.  
The treatment plans were created to achieve the dual aims of insuring that the minimum 
dose was at least 95% of the prescribed dose and that the maximum dose did not exceed 
107%.  In practice, dose variation within the target volume is usually held to no more 
than 10% of the prescribed dose.   
 The inhomogeneity across the treatment volume was thus kept to a minimum.  If 
this goal could not be achieved, then other beam arrangements were proposed to ensure 
that the over- and under-dosage volumes were minimized.  Isodose surfaces were 
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computed and evaluated for each plan to ensure adequate coverage of the target volume 
and compliance with the treatment protocol, as shown in Figure 24.  Dose volume 
histograms (DVH), as described in section 7 below, were calculated and evaluated to 
ensure proper dose coverage and appropriate dose limits on critical organs. 
 
 
 
Figure 24. 
Isodose color wash on transversal, coronal and sagittal CT images   
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Patient shown is #11 with original boost treatment plan.  Treatment GTV and PTV 
volumes are shown in white, inner and outer contour, respectively.  Boost prescription 
dose was 200 cGy for 7 fractions for a total of 14 Gy .  Total treatment dose delivered 
was 60 Gy.  Dose color scale is shown on top right corner, from 20% (36cGy, blue) to 
103% (205 cGy, red).  Notice that 95% o of the prescription coverage (red line) covers 
the GTV target volume and due to blocking of optical structures slightly misses bottom 
portion of PTV volume.  Notice that global dose maximum is 208 cGy or 104% of the 
prescription dose (value shown top right). 
IV.5.  Treatment plans for volumes of physicians and segmentation methods 
 The efficacy of automated segmentation methods in radiation therapy can be 
evaluated by comparing hypothetical radiation therapy treatment plans based on 
computer segmentations with those generated by radiation oncologists.  For this purpose, 
the CT images that were used for the planning of the actual treatment were also used to 
independently generate new, hypothetical treatment plans.  However, only the cone down 
treatment plan was evaluated since the treatment volume generated for this plan is based 
solely on the gross tumor volume.  This means that the computer segmentation methods 
cannot be used to define the initial brain treatment unless there is a method to properly 
identify edema to be included in the treatment volume.  Nevertheless, the use of the GTV 
volume is appropriate since the GTV receives the greatest radiation dose and is the most 
important volume in radiation therapy planning.   As mentioned before, over 89% of 
tumor recurrences have been found to be located within the GTV (5,6,8). 
Since the intra-operator variability has already been evaluated, the physician 
treatment plans used for comparison were developed based upon the average GTV 
created by each of the radiation oncologists.  A software program to generate these 
average volumes was written in Interactive Data Language software version 5.4 and can 
be found in Appendix C.  The use of one GTV volume per physician resulted in one 
treatment plan for each radiation oncologist.  Similarly, a radiation therapy treatment 
plan was created to correspond to each of the computer segmentation generated tumor 
volumes.  The computer segmentation volumes were transferred to the CT image 
coordinate system used for treatment planning by means of the CT-MRI image 
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registration as described in Chapter III.  A software program was written to merge the 
new computer segmentation gross tumor volumes into the treatment planning files as 
described before (Figure 6). 
It is important to note that one of the findings from chapter III shows that the 
automated segmentation methods consistently under-segment significantly in the superior 
and inferior borders of the tumor volume.  Using this insight, some novel modifications 
have been incorporated in the segmentation volumes to be applied in radiation therapy.  
The understanding of the radiation oncologists contouring described in the previous 
chapter were translated to the segmentation methods to improve the resulting computer 
generated PTV volumes.  A margin was added in the vertical direction to the gross tumor 
volume obtained by the kNN and KG methods.  Copying the most superior and inferior 
contour produced by the segmentation method to the immediately adjacent CT slice 
simulated the process used by radiation oncologists to identify the most superior and 
inferior GTV contours, as described in the previous chapter.   This procedure added a 4 
mm margin in each vertical direction.  A visual comparison of the resulting GTV as 
compared to the physician GTV provided visual evidence of the appropriateness of this 
expansion technique.  This modification could automatically be applied to the results of 
the current segmentation methods.   
As previously noted, the definition of the PTV is crucial to effective plan 
evaluation and comparison.  For a fair comparison, the PTV for both physicians and the 
automated segmentation methods were determined using the 3D automatic margin 
expansion function of the treatment planning system with automatic exclusion of the 
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skull bone as defined in the previous section.  These contours are created such that each 
point is located no closer than the specified distance from the initial contours in three-
dimensional space (see Figure 25).     
 
 
Figure 25. 
Representation of a 3D automatic PTV margin expansion 
 
Figure shows a 3D automatic PTV (outer outline shown in green) margin expansion in a 
MRI axial view, CT axial view, CT reconstructed coronal view, and CT reconstructed 
sagittal view for the GTV (inner outline shown in red).  Patient 8 is shown with a 2 cm 
automatic expansion around Physician 1 average GTV. 
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All commercial 3D treatment planning systems perform the margin expansion 
function automatically.   For the Focus system a version of the 3D Rolling Ball algorithm 
is used.  Various researchers (43,44) have previously defined the principles of the 
algorithm. 
The margin of the PTV remained the same (1-2 cm) as used for the actual patient 
treatment (see Table 6). No additional trimming around critical structures or manual 
modifications was performed to eliminate human bias when comparing treatment plans.  
The critical structure definitions remained the same as those used in the preparation of the 
actual patient treatment plans.  This eliminated the introduction of additional variations in 
size and location of critical structure during plan evaluation. 
 Based on the PTVs obtained, five new treatment plans were created for each 
patient, one for each of the contours by the radiation oncologists and the computer 
segmentations.  The FOCUS treatment planning system with upgraded software was used 
to create these new patient treatment plans (Versions 4.0.2-4.0.3).  These plans had the 
same basic treatment techniques as used in actual patient treatments described in the 
previous section.  The number of beams, the dose prescription and fractionation, and the 
positioning of the patient all remained unchanged.  All calculation parameters (resolution, 
inhomogeneity, dose calculation algorithm, etc.) were also kept the same as those of the 
actual patient treatments discussed in the previous section.   
 The multi-leaf collimator for each beam used to block normal tissue was created 
using the automatic MLC margin function.  There was slight variation in beam apertures 
and MLC definition based on the new PTV volumes.  The margin remained consistent 
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with what was used for the actual patient treatment (0.8 cm around the PTV).  No 
additional blocking to the visual structures was added in the interest of avoiding 
additional bias in the comparison.  This ensured that the actual and hypothetical treatment 
plans were consistent and that the resulting data could be meaningfully compared. 
 Isodose surfaces were computed for these plans to ensure adequate coverage of 
the target volume while complying with the applicable brain treatment protocol.  As with 
the standard brain treatment protocol of the facility, coverage of the PTV volumes with 
the 95% isodose line was considered acceptable.  The resulting hypothetical treatment 
plans were then transferred to the laptop computer for further evaluation and subsequent 
comparison to the actual plans (as modified to make comparison more meaningful). 
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IV.6.  Expert definition 
 For the purpose of data analysis in this chapter, Physician 1 was selected as the 
“baseline expert” in delineating brain gross tumor volume.  This decision was based on 
the following factors:  (1) he achieved the smallest intra-operator variability (See Chapter 
II); (2) he is a radiation oncologist specializing in neuro-oncology with over ten years of 
clinical practice experience treating over 200 glioma brain tumor patients; and (3) he has 
participated in several multi-center brain study trials resulting in publications and 
treatment plans which involved peer review (4,33).  Additionally, Physician 1 was 
responsible for defining and approving the actual radiation treatment for all eleven 
patients evaluated in this study.   
 Based on the above definition of the study’s baseline expert radiation oncologist, 
the average planning target volume generated by Physician 1 (PTV1) was used as the 
reference volume against which the treatment plans generated from the tumor volumes 
defined by physicians two and three, as well as the automated MRI segmentation 
methods, were compared.     
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IV.7.  Treatment plan evaluation techniques in current clinical practice 
 Many methods have been used to quantitatively evaluate treatment plans by 
reducing the vast amount of 3D dose data to a single number or a few numbers.  Some of 
the quantitative methods most commonly used are dose statistics , dose-volume 
histograms (DVHs), and conformity indices.  
IV.7.a.  Dose statistics 
 Dose statistics are single numbers that characterize some aspect of the 3D dose 
distribution.  A dose estimate can be determined for a particular volume of interest (VOI), 
for the treatment volume (PTV), or for the entire patient.  While dose statistics are 
simplistic, they remain an important tool in comparing dose coverage for a region of 
interest between different treatment plans.  The most common dose statistic values are 
minimum dose (Dmin), maximum dose (Dmax), and average dose (Dave).  The first two 
quantities are defined as expected.  The average dose is based on the calculation of the 
dose at each one of a large number of discrete points (grid points), uniformly distributed 
in the volume of interest.  The average dose can be expressed by the equation: 
∑=
V
kjiave DN
D ,,
1  [Equation 1] 
where N is the number of grid points, i,j,k are the column, row and level index, 
respectively, and Di,j,k is the dose at the grid point i,j,k located inside the volume of 
interest V (41). 
IV.7.b.  Cumulative dose volume histograms 
Another accepted way to summarize the 3D dose distribution to a manageable 
size while retaining important information about dose variations is the cumulative dose 
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volume histogram (DVH).  DVHs provide a way of presenting the user with a synopsis of 
the dose to a given structure.  They are currently and prominent features of modern 
treatment-planning systems and were first introduced in order to compare rival treatment 
plans.  A cumulative DVH (in practice referred as DVH) is a graph of volume plotted 
against dose (45).   The interpretation of the graph is that the ordinate of a point on the 
graph represents the volume which receives at least the dose associated with the point’s 
abscissa i.e., receives that dose or more (Figure 26).  By definition, then, the value at the 
dose origin will be the full volume of the VOI because the entire volume receives at least 
zero dose.  Even though they are called histograms, it is important to note that cumulative 
dose volume graphs represent a continuous distribution of dose.   
A DVH gives the percent of a structure that receives at least a certain dose as a 
function of dose.  This display can quickly demonstrate the proportion of a tissue that is 
under- or over- dosed with respect to a prescribed dose.  It can also demonstrates whether 
dose differences between two plans are at a critical or non-critical dose.  For illustration, 
Figure 27 schematically shows different DVHs for three possible target dose 
distributions.  
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Figure 26. 
Schematic representation indicating generation of a cumulative DVH   
 
The ordinate of a point on the graph represents the volume which receives at least the 
dose associated with the point’s abscissa.  That is, receives that dose or more.  By 
definition, then, the value at the dose origin will be the full volume of the volume of 
interest because the entire volume receives at least zero dose.   
 
(From Goitein 1992 (45), reproduction permitted by Elsevier) 
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Figure 27. 
DVH for different target volume coverage 
 
DVH for target volume showing:  (a) uniform coverage, (b) small under-dosage region,  
and (c) small overdose region.  Adapted from Goitein 1992 (45). 
 
 
IV.7.c.  Conformity index 
 Although DVHs provide very accurate information about the dosimetric 
properties of treatment plans, it may be difficult to infer the clinical significance of 
differences in rival treatment plans using DVHs alone.  Conformity indices were 
introduced as one of the guidelines for radiosurgery treatment planning by the Radiation 
Therapy Oncology Group (RTOG) to evaluate the dosimetric properties of a treatment 
plan (46).  Conformity indices have been used extensively as a tool to define the 
conformation of a 3D treatment plan, that is, how close the prescription isodose covers 
the defined target volume PTV.  It has also been used extensively to compare different 
treatment plans or treatment planning modalities (47-49). 
The conformity index (CI) of a treatment plan is defined as the ratio of the 
prescription isodose volume (VPX) to the volume of the target (VPTV):  
       
PTV
PX
V
VCI =               [Equation 2] 
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where VPX  is the isodose volume within the percent isodose surface that encompasses the 
target, usually the prescription isodose.  CI evaluates the dose distribution with emphasis 
on the size of the target volume compared to the size of the prescribed treatment volume.   
 The conformity index is unity for a perfect hypothetical fully conformal 
treatment, i.e. the prescription isodose surface coincides exactly with the boundaries of 
the PTV.  An increase in the value shows that the isodose surface is larger than the PTV, 
which results in undesirable radiation to normal tissues.  A decrease in value to less than 
one represents under-treatment of the PTV.   According to the Radiation Therapy 
Oncology Group (RTOG), a value between 1.0 and 2.0 is assumed to be within the 
treatment protocol for brain radiosurgery (46).  A value less than 1.0 but greater than 0.9, 
or between 2.0 and 2.5, are classified as minor deviations.   All other values are classified 
as major deviations (see Figure 28).   
 
0.0 0.9 
1.0 
2.0 2.5 3.01.50.5 
un-acceptableminordeviations acceptableun-acceptable 
 
Figure 28. 
Scale representing range of conformity index values 
 
Note that values within 1.0-2.0 are considered acceptable.  Values within 0.9-1.0 or 2.0-
2.5 are considered minor deviations.  Any value beyond this range is considered an 
unacceptable conformity of the treatment plan (46). 
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IV.8.  Treatment plan analysis methods for this study 
This study compares the two treatment plans created from the segmentation 
methods with the three treatment plans created from the physicians’ outlines based on the 
dose statistics, the dose volume histograms and the conformity indices.  As described in 
Section IV.6, the average volume determined by Physician 1 is used as the reference.  
Therefore, all comparisons were based on exploring the coverage of the plans created on 
the volumes of the physicians and segmentation methods as compared to the coverage 
given to the volume created by Physician 1 (PTV1).  All plan comparisons were 
performed qualitatively, by visual inspection of the dose distribution; and quantitatively, 
by the use of various dose statistics, dose volume histograms, and treatment plan 
conformity indices. 
IV.8.a.  Dose statistics 
All dose statistics for this analysis were generated using the Focal Vue treatment 
planning evaluation software (Computerized Medical Systems, St.Louis, MO) running on 
the Dell Inspiron 7000 laptop computer (Dell, Round Rock, TX).  The basic dose 
statistic, i.e., average dose, minimum dose, and maximum dose were determined for each 
treatment plan created with reference to the PTV of Physician 1 using a 2 mm calculation 
grid.  Since the minimum dose could be misleading in interpreting dose uniformity in the 
target volume, an additional calculation of the percent volume that receives less than the 
prescription isodose (95%) was also determined. 
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IV.8.b.  Cumulative dose volume histogram 
An analysis of the cumulative dose volume histogram for each of the plans was 
performed in a manner similar to the comparison proposed by Verhey and co-workers (49).  
The amount of normal brain tissue that would be treated with the different physician 
volumes and computer segmentation was calculated for all treatment plans and compared 
with the standard reference (Physician 1).  DVHs were obtained using a calculation grid 
of 2 mm.   
IV.8.c.  Conformity index 
The conformity index was used to compare the treatment plans in a manner 
similar to that set forth in previously published research (48,49).  The degree of conformity 
of each individual treatment plan was evaluated by the radiation conformity index (CI) 
defined as:  
    
iPTV
i
i V
VCI
)(
)( 95=     [Equation 3] 
where V95 represents the volume of the 95% isodose (prescription isodose) and VPTV is 
the planning target volume for the treatment plan being evaluated, as defined in section 3 
of this chapter.  The volume of the 95% isodose coverage was derived from the absolute 
dose volume histogram information produced by the treatment planning evaluation 
software.  The conformity index of each of the treatment plans was calculated and 
denoted as CI1, CI2, and CI3 for the three physicians, CIknn for the plan generated by the 
kNN segmentation method contours, and CIkg for the plan generated by the knowledge 
guided system contours.   
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 The conformity index of Eq. 3 is used in clinical practice to compare plans 
generated from the same planning volume (PTV).  However, in this study it was of 
particular interest to compare plans developed from different PTVs.  In particular, it was 
intended to evaluate if the plans based on computer segmentations are acceptably 
conforming to the expert physician.  To perform this evaluation a novel system of cross-
conformity indices was developed based on each treatment plan but using the Physician 1 
target volume (PTV1) as the standard.   
 
MRI CT
PTV1 PTV2 PTV3 PTVkNN PTVKG
Treatment
Plan Phys1
Treatment
Plan Phys2
Treatment
Plan Phys3
Treatment
Plan kNN
Treatment
Plan KG
CI1 CI2 CI3 CIkNN CIKG
CCIkNN-1 CCIKG-1CCI3-1CCI2-1
 
 
Figure 29. 
Evaluation strategy based on conformity indices  
 
PTV1 represents the average PTV of the expert physician; PTV2 and PTV3 represent the 
average PTV of physicians 2 and  3; PTVkNN and PTVKG represent the  PTV of resulting 
from the computer segmentation methods.  The cross-conformity indices (CCIi-1) are 
calculated by taking the dose distribution from each plan based on the outline of the 
expert physician (PTV1). 
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The treatment plan evaluation strategy is schematically outlined in Figure 25 
above.  For example, CCI21 is the conformity index obtained using the volume dose 
distribution of the plan based on the outlines of physician 2, but comparing the resulting 
isodose volume to the planning target volume of physician 1.  It is important to note that 
the original description of CI compares the size of the prescription treatment volume to 
the size of the PTV since it assumes that the plan is evaluated and approved.  This 
process assumes that the prescription isodose covers the actual target volume (Figure 
30(a)).  For the case of cross-conformity indices, the evaluated plan coverage is based on 
an entirely independent target volume (PTV1) from the original plan and does not 
consider spatial location of the isodose volume evaluated since no plan approval was 
performed.  Figure 30(b) shows an example of a conformity index of 1 but with an 
isodose volume that would miss much of the target.   
 (a)            (b)  
Figure 30. 
Target volume isodose spatial coverage  
 
Figure represents PTV (solid volume in blue) and reference isodose volume (represented 
by outline in red).  Case (a) represents the ideal case and (b) the case of isodose spatial 
misplacement with respect to the PTV.  Note how both cases would yield a conformity 
index of about 1 since the isodose volume is equal to the actual PTV.   
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Therefore, the definition of conformity index was modified similar to Van’t Riet 
et.al (50).  A correction factor is introduced that accounts for coverage of the target: 
PXPTV
PTV
V
VCF
≥
=
)(
   [Equation 4] 
where VPTV is the planning target volume and  (VPTV )≥PX is the volume of target 
receiving a dose equal to or greater than the reference or prescription dose.  The 
correction factor increases as the proportion of PTV covered by at least the prescription 
isodose decreases.  This is based on the original definition of conformity index that 
evaluates coverage based on the minimum prescription dose that encompasses the target 
(47,50).  Therefore, the conformity index is modified to include specifically the target 
volume enclosed by the prescription isodose selected:  
PXPTV
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V
VCI
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    [Equation 5] 
Using the spatial co-location correction factor (Eq. 4) and above definition of 
conformity index (Eq. 5) results in a cross-conformity index definition for physician or 
segmentation plan, j, with respect to Physician 1 and 95% prescription isodose as:   
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The average and range of cross-conformity indices of cross-operator plans (CCI2-1 and   
CCI3-1) was calculated and compared to the average and range of cross-conformity 
indices of the computer segmentation plans (CCIknn-1 and CCIkg-1, respectively).   
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IV.9.  Post-treatment evaluation methods 
 
The validation technique described above compared an expert treatment plan with 
other hypothetical (research) treatment plans.  This section introduces a novel approach 
to evaluate treatment plans based on the outcome of the actual clinical radiation treatment 
as seen on post-treatment images.  An analysis was performed to identify radiation 
damage in tumor and normal tissue, as well as treatment failure in active tumor.  These 
results were used to compare what would have been obtained by using the hypothetical 
treatment plans.   
 The clinical facility’s routine follow-up procedures after completion of a radiation 
treatment course include the administration of an MRI.  The imaging protocol for the 
post-treatment MRI is similar to the pre-treatment MRI described above (see Chapter II).   
The primary study set used for this evaluation consisted of T1 scans obtained after 
administration of 0.1 mmol/kg body weight of gadolinium (Gd) MRI contrast material 
(Gd-DTPA) and using a standard spin-echo (SE) sequence with a repetition time 
(TR)/echo time (TE) = 400/8 or TR/TE=525/17 ms. For cases of non-tumor 
enhancement, T2 axial images were used as the primary study set.  T2 images were 
obtained with a TR/TE=3000/104 ms or TR/TE=4000/96 ms. Additional sagittal and 
coronal images were available to help identify structures of interest in the axial scans. 
Only eight of the eleven patients participating in this study returned to the University of 
South Florida to have their post-treatment MRI performed.  Therefore, the results of these 
eight patients with follow-up MRI studies were used to develop and analyze the proposed 
treatment evaluation tool (see Table 7).   
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Table 7. 
Patient post-treatment imaging studies 
 
 
 
Case 
 
Post-MR 
available 
 
Tumor 
Enhanced 
Post-treatment MR 
(days from end of  
radiation treatment) 
 
1 
 
Yes 
 
No 
 
502 
2 Yes No 378 
3 Yes Yes 146 
4 No N/A N/A 
5 No N/A N/A 
6 Yes Yes 363 
7 No N/A N/A 
8 Yes Yes 112 
9 Yes Yes 64 
10 Yes Yes 437 
11 Yes Yes 48 
 
 
 The evaluation procedure is presented graphically in Figure 31 below.  
Additionally, Figure 1 from Chapter I shows a flowchart of the complete design of the 
project, including the evaluation mechanism to determine the accuracy of treatment 
planning based on follow-up imaging.   
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Figure 31. 
Schematic display of post-MRI validation process  
  
 An expert neuro-radiologist identified three different tissue types on the post-
treatment MRI:  residual or recurrent tumor tissue (tumor), radiation damage in the tumor 
(necrosis), and radiation damage in normal tissue (normal tissue damage).  These three 
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areas were contoured by the neuro-radiologist on the axial primary study set (post-
contrast T1 or T2) axial MRI scans in its original MRI imaging position using the Focal 
Ease contouring software.  The neuro-radiologist utilized digital displays of all the other 
MRI post-treatment scan types performed on the patient, which include coronal and 
sagittal scans, to aid in identifying these three different tissue types.  Because this precise 
contouring is very time consuming, it was performed in three slices through the central 
area of the tumor volume for each of the 8 patients with post-treatment MRI.    
 The following is a note regarding the limitations of the post-treatment MRI 
available in this study.  New and improved imaging modalities are constantly being 
adopted to improve tumor volume and tissue classification protocols.  Recent studies 
have shown that several different imaging modalities must be used to maximize accuracy 
in the differentiation of real tumor tissue from regular brain tissue or necrosis (2,51).  When 
MRI is used to define recurrence, it is often difficult to be certain whether the enhancing 
abnormality represents true tumor recurrence or radiation-induced necrosis (5).  Until 
newer imaging techniques become routinely available, MRI scans, despite their 
limitation, offer the best assessment of tumor progression for the purposes of tumor 
follow-up.  Therefore, the application of the proposed evaluation technique to the post-
treatment image set may not yield the most accurate results.   However, this method is 
used here as a tool to analyze the relative efficacy of the radiation treatment.   The 
proposed evaluation technique could be applied to any imaging modality, resulting in 
more accurate evaluation results and possible wider medical applications.  
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The primary follow-up MRI study set was registered to the CT coordinate system 
used for treatment planning with the Focal Fusion registration software.  The expert 
radiation oncologist verified the registration results in a similar manner as described in 
Chapter II.  The resulting transformation matrix was applied to transform the post-MRI 
contours into the pre-treatment CT image coordinate system.  Software programs were 
created using IDL to perform these contour transformations and to incorporate the new 
contours into the original patient contour dataset as described in Chapter III.  This 
procedure permitted the comparison of the original patient treatment plan with the 
hypothetical plans; the actual patient results were then used to evaluate the treatment 
results in a novel manner.   
 Based on the tissue classification obtained from the post-treatment follow-up 
MRI, dose volume histogram distributions were calculated for the actual treatment plan 
and for the hypothetical treatment plans created from the tumor volumes created by the 
physicians and the automated computer segmentation.  A calculation grid of 1 mm was 
used for structures less than 25.0 cm3 to increase accuracy.  Cumulative dose volume 
histograms were specifically calculated for the following regions as delineated by the 
neuro-radiologist: (a) tumor, (b) necrosis, and (c) damaged normal tissue.  These different 
areas represent tissue that received radiation from the actual patient treatment.  
Additionally, graphical evaluation of isodose coverage was compared for the areas of 
interest irradiated under the different treatment plans.   
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IV.10.  Results 
IV.10.a.  Segmentation GTV volume expansion 
As described in section 5, the resulting kNN and KG volumes were modified with 
the addition of a margin in the vertical direction of the GTV. 
 
 
(a) Original GTV 
 
 
(b) Extended GTV 
 
 
 
Figure 32. 
GTV vertical expansion 
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 Figure 32 shows the result of implementing a vertical expansion for the GTV of 
patient 9.  The original and expanded GTV resulting from kNN (inner contour displayed 
in magenta) and KG segmentation method (inner contour displayed in cyan) are 
displayed as compared to the physician 1 average GTV (outer contour displayed in 
orange).  A visual comparison of the resulting expanded GTV as compared to the 
physician 1 for this example in coronal views shows the close approximation of the 
volume in the vertical direction.  Additionally, a 3D representation of the reconstructed 
volumes shows a closer agreement with physician 1. 
 
 
 
Figure 33. 
Example of original GTV for kNN and KG compared to physician 1 
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Figure 34. 
Example of expanded GTV for kNN and KG compared with physician 1 
 
Figures 33 and 34 show another example of the results of expanding the GTV for 
kNN (inner contour displayed in magenta) and KG segmentation method (inner contour 
displayed in cyan) for patient 11.  A visual comparison of the resulting GTV as compared 
to the physician 1 average GTV (outer contour displayed in orange) for this example 
shows the close approximation of the volume.  Similar results were obtained for the other 
ten patients.  No additional analysis was performed since the GTV modification accounts 
for less than 5% of the total volume size. 
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IV.10.b. Planning target volumes 
The PTV for both physician and segmentation methods was determined using the 
automatic margin expansion technique as previously defined.  Figure 35 shows the PTV 
resulting from the modified kNN segmentation for patient 11 as compared to the PTV 
resulting from the average physician 1 GTV.  Notice the close alignment and match of 
the volume resulting after the expansion compared to original GTV (Figure 33).  
Similarly, Figure 36 shows an example of the results for the KG volume expansion.   
 
Figure 35. 
Example of kNN segmentation PTV compared with physician 1 PTV 
 
Figure shows PTV resulting from kNN segmentation method (inner contour displayed in 
red) compared to PTV of Physician 1 (outer contour displayed in yellow) for patient 11.  
Images displayed show axial, coronal and sagittal MR views plus a 3D representation of 
the reconstructed volumes.   
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Figure 36. 
Example of KG segmentation PTV compared with physician 1 PTV 
 
Figure shows PTV resulting from KG segmentation method (inner contour displayed in 
red) and compared to PTV of Physician 1 (outer contour displayed in yellow) for patient 
11.  Images displayed show axial, coronal and sagittal MR views plus a 3D representation 
of the reconstructed volumes. 
 
 
Table 8 shows the size of the resulting PTVs in cm3.  Note similar values obtained 
for the volumes from the kNN and KG segmentation as compared with physician 1.  
Paired t-test with Bonferroni correction for multiple tests showed that PTV2 and PTVkNN 
are significantly different from the PTV1.   
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Table 8. 
Values of resulting PTVs for physicians and segmentations methods 
 
 
Patient 
# 
 
PTV1 
(cm3) 
 
PTV2 
(cm3) 
 
PTV3 
(cm3) 
 
PTVkNN 
(cm3) 
 
PTVKG 
(cm3) 
 
1 
 
 
130 
 
134 
 
131 
 
113 
 
N/A 
2 193 187 200 
 
167 
 
N/A 
 
3 248 263 247 
 
208 
 
N/A 
 
4 220 236 227 
 
196 
 
197 
 
5 468 500 492 
 
422 
 
409 
 
6 369 393 390 
 
390 
 
N/A 
 
7 231 251 222 
 
182 
 
205 
 
8 305 331 317 
 
284 
 
308 
 
9 131 155 134 
 
120 
 
107 
 
10 150 166 166 
 
139 
 
157 
 
11 
 
164 162 156 125 126 
 
Average 
 
237 ± 107 
 
253 ± 114 
 
244 ± 114 
 
213 ± 107 
 
N/A 
 
 
IV.10.c.  Plan comparison 
The resulting treatment plans were compared quantitatively by the use of dose 
statistics, DVHs and CIs as described in section 9 of this chapter.    Plans were created 
based on their respective planning target volumes as described in section 5.  All plans 
were evaluated by comparing the coverage of the planning target volume of reference 
Physician 1 (PTV1).   
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IV.10.d.  Dose statistics 
Table 9 shows the average dose statistics for the different treatment plans as 
percent of boost treatment dose (see Table 6) and part of the planning volume not 
receiving at least 95% of the boos dose.  All values are displayed in percent volume of 
PTV.  Note that the mean average dose is larger than the prescribed dose (95% of boost 
dose) for all treatment plans indicating good target coverage.  Paired t-tests with 
Bonferroni correction indicate that the kNN treatment plans have a significantly lower 
mean dose than plans of Physician 1.  
 
 
Table 9. 
Average dosimetric values for PTV1 from the different treatment plans 
 
 
 
Dosimetric 
Quantity 
 
 
Physician 1 
(%) 
 
 
Physician 2 
(%) 
 
 
Physician 3 
(%) 
 
 
KNN 
(%) 
 
 
KG 
(%) 
 
 
Average  
dose 
99.8 ± 2.1 99.8 ± 1.1 99.8 ± 1.2 99.5 ± 1.4 99.3 ± 0.6 
 
Maximum 
dose 
103.9 ± 2.1 104.2 ± 2.2 104.0 ± 2.1 104.2 ± 2.1 104.2 ± 2.1 
 
Minimum 
dose 
91.4 ± 3.1 87.2 ± 10 90.6 ± 3.3 75.0 ± 16.6* 79.3. ± 11.9 
 
Volume 
below 
95% isodose 
1.0 ± 1.4 1.3 ± 1.9 1.1 ± 1.3 3.5 ± 2.4* 4.5 ± 3.4 
 
(*) statistically significant as compared with Physician  1 
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The dose maximum and minimum values were used to evaluate the homogeneity 
of the dose distributions from the automated segmentation plans and the physician plans.  
Note similar results for all plans regarding maximum dose in Table 9.  Results from 
minimum dose seem to indicate that kNN and KG lead to less homogeneous plans.  Since 
the minimum dose could be misleading in interpreting dose uniformity in the target 
volume, an additional calculation of the percent volume that receives less than the 
prescription dose (95%) was determined.  It can be seen that even though the dose is not 
as homogeneous when using the plan obtained from the KG and kNN volumes, 
nevertheless, the amount of underdose volume is insignificant for clinical purposes (<5% 
on average).  In practice dose variation within the target is usually held to no more than 
10% of the prescribed dose. 
IV.10.e.  Cumulative dose volume histogram 
A comparison of the amount of normal brain tissue that would be treated with the 
different physician volumes and computer segmentation was calculated and compared 
with the plan from Physician 1.  Table 10 shows the average dose to normal brain 
resulting from boost plans as percentage of total prescription dose (95% of total boost 
dose (Table 6)).  Normal brain was calculated by subtracting the PTV1 volume from the 
total brain volume (Normal brain volume = Total brain volume – PTV1).   Note the 
slightly less dosage of normal brain by using the plans from the kNN and KG 
segmentation.  Paired t-tests showed that there is no statistical difference in normal tissue 
dose between the plans from the different physician or segmentation GTVs as compared 
with physician 1. 
110 
Table 10. 
Average dose to normal brain irradiation for boost plans 
 
 
 
Patient 
# 
 
Physician1 
(%) 
 
Physician2 
(%) 
 
Physician3 
(%) 
 
kNN 
(%) 
 
KG 
(%) 
 
1 
 
29.4 
 
28.9 
 
28.9 
 
26.7 
 
N/A 
 
2 
 
32.2 
 
30.0 
 
32.2 
 
28.9 
 
N/A 
 
3 
 
46.0 
 
48.0 
 
46.0 
 
43.0 
 
N/A 
 
4 
 
36.0 
 
39.0 
 
41.5 
 
39.5 
 
36.5 
 
5 
 
60.0 
 
65.0 
 
67.0 
 
65.5 
 
55.5 
 
6 
 
43.0 
 
41.5 
 
44.5 
 
43.0 
 
N/A 
 
7 
 
40.6 
 
42.8 
 
39.4 
 
35.6 
 
38.9 
 
8 
 
45.0 
 
47.5 
 
46.5 
 
43.5 
 
47.5 
 
9 
 
34.5 
 
39.0 
 
35.0 
 
33.0 
 
27.0 
 
10 
 
36.7 
 
39.4 
 
39.4 
 
36.1 
 
37.8 
 
11 
 
41.0 
 
41.0 
 
39.5 
 
35.5 
 
35.5 
 
Average 
 
40.4±8.4 
 
42.0±9.7 
 
41.8±10.0 
 
39.1±10.4 
 
39.8±9.2 
 
 
Figure 37 shows a graphical comparison of the DVHs for patient 11.  Notice that 
the KG and kNN treatment plans give slightly less dosage to normal brain tissue and 
maintain proper coverage of PTV1; i.e. dose ≥ 95%.  Similar results were encountered for 
the other patients. 
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Figure 37. 
Comparisons of DVHs for patient 11 for PTV1 and normal brain tissue 
 
Comparisons of DVHs for patient 11 showing PTV1 target volume (superior set of lines) 
and normal brain tissue (inferior set of lines) for (a) Physician 1 (solid line), Physician 2 
(dashed line) and Physician 3 (doted line) treatment plans; and  (b) Physician 1 (solid 
line), KG (dashed line), kNN (dotted line).   
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IV.10.f.  Conformity index 
The conformity index of each of the treatment plans based on their corresponding 
PTVs was calculated and denoted as CI1, CI2, and CI3 for the three physicians, CIknn for 
the plan generated by the kNN segmentation method contours, and CIkg for the plan 
generated by the knowledge guided system contours.  This provided information on the 
degree of difficulty to design a plan that closely conforms to each outline.  Table 11 
shows the conformity indices for all treatment plans.   
Table 11. 
Conformity index values for physicians and segmentation methods  
 
Patient 
# 
Physician 1 
CI1 
Physician 2 
CI2 
Physician 3 
CI3 
kNN 
CIkNN 
KG 
CIKG 
 
1 
 
1.34 
 
 
1.28 
 
1.31 
 
1.32 
 
N/A 
2 1.52 
 
1.51 1.50 1.54 N/A 
3 1.41 
 
1.43 1.40 1.45 N/A 
4 1.35 
 
1.37 1.36 1.38 1.41 
5 
 
1.57 1.53 1.53 1.62 1.59 
6 
 
1.41 1.34 1.40 1.35 N/A 
7 
 
1.48 1.45 1.48 1.56 1.51 
8 
 
1.42 1.36 1.42 1.46 1.47 
9 
 
2.08 1.97 2.07 2.10 2.28 
10 
 
1.35 1.36 1.36 1.40 1.38 
11 
 
1.50 1.50 1.50 1.59 1.53 
 
Average 
 
1.49 ± 0.21 
 
1.46 ± 0.19 
 
1.48 ± 0.21  
 
1.52 ± 0.22  
 
N/A 
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Note that all values displayed in Table 11, except for patient 9, are within the 
acceptable range as defined in Figure 28.  Patient 9 resulted in conformity index value 
considered a minor deviation but acceptable for treatment planning.  A comparison with 
the data from table 6 shows that a better conformity index, that is, values closer to one, 
results for treatment plans with a larger number of fields.  Statistical analysis showed that 
all plans for each patient were created to the same level of conformity. 
 
Table 12. 
Values of cross-conformity indices 
 
 
Patient 
# 
 
Physician 1 
CCI1-1 
 
Physician 2 
CCI2-1 
 
Physician 3 
CCI3-1 
 
kNN 
   CCIkNN-1 
 
KG 
   CCIKG-1 
 
 
1 
 
1.42 
 
1.43 
 
1.42 
 
1.34 
 
N/A 
2  1.52 
 
1.49 
 
1.55 
 
1.39 
 
N/A 
3  1.43 
 
1.53 
 
1.41 
 
1.31 
 
N/A 
4  1.42 
 
1.55 
 
1.48 
 
1.39 
 
1.49 
 
5 
 
1.57 
 
1.64 
 
1.61 
 
1.49 
 
1.52 
 
6 
 
1.53 
 
1.60 
 
1.59 
 
1.63 
 
N/A 
 
7 
 
1.49 
 
1.58 
 
1.45 
 
1.30 
 
1.38 
 
8 
 
1.43 
 
1.48 
 
1.48 
 
1.39 
 
1.52 
 
9 
 
2.08 
 
2.34 
 
2.11 
 
1.94 
 
2.30 
 
10 
 
1.37 
 
1.51 
 
1.51 
 
1.41 
 
1.51 
 
11 
 
1.51 
 
1.48 
 
1.46 
 
1.32 
 
1.28 
 
Average 
 
1.52 ± 0.19 
 
1.60 ± 0.25 
 
1.55 ± 0.20 
 
1.45 ± 0.19 
 
N/A 
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IV.10.g.  Cross-conformity indices 
Table 12 shows the values for cross-conformity indices (CCIs) as defined by Eq. 
6 above.  These values were based on the comparison of the 95% isodose coverage  for 
the reference PTV and a correction factor to account for location of the dose volume.  
Notice how the CCIs with correction for Physician 1 are very close to original CI 
calculated for physician one (Table 11).  This confirms that the correction factor is 
applied correctly and does not alter the actual definition of CI when the reference isodose 
volume covers the evaluated target volume.  The correction factor only penalizes the CI 
for cases where the isodose volume does not cover the target volume. 
Most cases in Table 12 show equal conformity.  Paired t-tests with Bonferroni 
correction for multiple comparisons on the data in Table 12 showed only a statistical 
difference between CCI1-1 and CCI2-1. 
IV.10.h.  Post-treatment evaluation 
The post-treatment MR images were used to compare the resulting volumes that 
were irradiated with those that would be irradiated under the different treatment plans.  
Figure 38 shows the dose coverage of the different tumor volumes identified in the post-
MR for patient 11.  Figure 38(b) is an example of the excellent agreement found in 
location between the area identified as tumor by physician 1 and the area identified as 
tumor in post-MR by the neuro-radiologist.  Similar results were obtained for the other 
patients confirming the selection of Physician 1 as the expert radiation oncologist for 
purpose of this study.  Figures 38 shows how the plan and PTV resulting from physician 
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1 and the automated segmentation methods provide coverage to the area identified as 
tumor and necrosis that represent the actual treated region. 
       (a)     (b) 
       (c)     (d)  
Figure 38. 
Post-MRI and isodose coverage for tumor and necrosis for patient 11  
 
Figure (a) shows volume of tumor (outer volume in red) and necrosis (inner volumes in 
green) identified in axial post-MR image for patient 11.  Figures (b)-(d) show the same 
volumes together with average GTV (next outline) and PTV (outer outline) for physician 
1 (a), kNN (b) and KG (d).  The isodose colorwash is overlaid in the figures to display 
doses from 20% (outside starting in shades of blue) to 100% (inner in shades of red) 
resulting from the plans generated by each PTV.    
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  (a)          (b) 
  (c)           (d) 
 
Figure 39. 
Post-MRI and isodose coverage for tumor, necrosis and damaged tissue 
 
Figure (a) shows tumor (two outer contours in red), necrosis (contours inside tumor 
displayed in green) and damaged normal (tissue surrounding tumors displayed in blue) 
for patient 9 on post MRI axial image.  Figures b,c,d, show the dose distribution resulting 
from plans based on volume from Physician 1, kNN and KG respectively.  Dose 
colorwash display shows dose distribution from 20% (outside shades in blue) to 100% 
(inner shades in red).   
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Figure 39 shows an example of volumes identified in the post-MR and the 
coverage resulting from the different treatment plans.  Notice that even though kNN and 
KG have a slightly smaller treatment area, there is still coverage of the area that was in 
fact treated, i.e. tumor, necrosis and damaged normal tissue. 
Cumulative dose histograms were calculated for the areas identified as (a) tumor, 
which may represent tissue identified as GTV in the actual treatment plan; (b) necrosis, 
which may represent tumor tissue that was targeted by the treatment; and (c) damaged 
normal tissue, which may be correlated with inaccuracies in the used tumor definition or 
additional area treated due to the PTV margin expansion.  All data is summarized in 
tables 13, 14 and 15 in percentages of boost prescription dose.  Values shown are in 
percentages of boost prescription dose.  The volume (column 2) is only the volume 
within the three slices contoured by the expert neuroradiologist.  Notice that due to non-
tumor enhancement of Patients 1 and 2, only necrosis and damaged normal was identified 
in the post-MR images. 
It was found that the coverage of these areas by the original patient treatment 
plans was on average of 98.2% ± 8.0%.  This shows that all areas identified in the post-
MR were treated by the treatment plan.  Small under-dosage was the result of additional 
blocking for patients with PTV close to adjacent critical organs.  Analysis of the coverage 
from the plans resulting from the segmentation methods shows an average of 99.1% ± 
2.8% and 98% ± 6.4% for kNN and KG, respectively.  Similar values were found for the 
physicians, indicating that both the physicians and the segmentation methods would have 
treated all tissues as identified in the post-MR.  Therefore, the use of an alternate plan 
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resulting from the automated methods would have yielded irradiation areas that are in 
agreement with the areas identified from the actual patient treatment. 
 
 
 
Table 13. 
Data evaluation for post-MRI tumor volume   
 
 
 
Patient 
 
Volume 
(cm3) 
 
 
% Dose  
Phys.1 
 
% Dose  
Phys.2 
 
% Dose  
Phys.3 
 
% Dose 
kNN 
 
% Dose  
KG 
  
%Dose 
TXPlan 
 
 1* 
 
N/A 
 
N/A 
 
N/A 
 
N/A 
 
N/A 
 
N/A 
 
N/A 
 
 2* 
 
N/A 
 
N/A 
 
N/A 
 
N/A 
 
N/A 
 
N/A 
 
N/A 
 
3   
 
20.9 
 
98.5 
 
98.5 
 
98.5 
 
98.0 
 
N/A 
 
101.0 
 
6 
 
6.6 
 
99.0 
 
99.0 
 
99.0 
 
98.5 
 
N/A 
 
99.0 
 
8 
 
16.7 
 
100.0 
 
100.0 
 
100.0 
 
100.0 
 
100.0 
 
103.0 
 
9 
 
16.1 
 
103.0 
 
102.5 
 
103.0 
 
103.5 
 
100.5 
 
104.0 
 
10 
 
22.2 
 
95.0 
 
96.1 
 
96.1 
 
96.1 
 
96.1 
 
86.1 
 
11 
 
11.5 
 
100.0 
 
100.0 
 
100.0 
 
100.0 
 
100.0 
 
103.0 
 
Ave. 
 
15.7 
± 5.8 
 
99.3 
± 2.6 
 
99.4 
± 2.1 
 
99.4 
± 2.3 
 
99.4 
± 2.5 
 
N/A 
 
99.4 
± 6.7 
 
 
(*) Patients 1 & 2 did not show tumor on post-treatment MRI. 
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Table 14. 
Data evaluation for post-MRI necrosis volume  
 
 
Patient 
 
Volume 
(cm3) 
 
 
% Dose  
Phys.1 
 
% Dose  
Phys.2 
 
% Dose  
Phys.3 
 
% Dose 
kNN 
 
% Dose  
KG 
  
%Dose 
TXPlan 
 
1 
 
1.8 
 
99.4 
 
99.4 
 
99.4 
 
99.4 
 
N/A 
 
101.1 
 
2 
 
2.0 
 
98.9 
 
99.4 
 
99.4 
 
99.4 
 
N/A 
 
98.9 
 
3 
 
9.9 
 
98.0 
 
98.0 
 
98.0 
 
98.0 
 
N/A 
 
101.0 
 
6 
 
1.3 
 
98.5 
 
98.5 
 
98.5 
 
98.5 
 
N/A 
 
98.5 
 
8 
 
11.5 
 
100.0 
 
100.0 
 
100.0 
 
100.0 
 
99.5 
 
103.0 
 
9 
 
2.6 
 
103.5 
 
103.0 
 
103.5 
 
104.0 
 
98.5 
 
104.0 
 
10 
 
7.9 
 
97.8 
 
98.3 
 
97.8 
 
98.9 
 
99.4 
 
86.1 
 
11 
 
3.7 
 
100.0 
 
100.0 
 
100.0 
 
100.0 
 
100.0 
 
103.0 
 
Ave. 
 
5.1 
± 4.1 
 
99.5 
± 1.8 
 
99.6 
± 1.6 
 
99.6 
± 1.8 
 
99.8 
± 1.8 
 
N/A 
 
99.5 
± 5.7 
 
 
 
 Table 14 and 15 show the results of coverage for necrosis and normal tissue 
volume.  These were tissues that were also irradiated by the treatment.  Notice similar 
coverage with the plans resulting from the segmentation methods compared to physician 
1 and the actual treatment plan (last column).  Table 15 shows that the KG treatment plan 
for Patient 9 delivered a lower dose to the damaged normal tissue.  The tumor volume for 
this patient included a small enhancing area with cystic center in the posterior section of 
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the brain.  This was not identified by the KG method as is evidenced in the 3D 
reconstruction in Figure 32. This effect was discussed in the previous chapter. 
 
 
Table 15. 
Data evaluation for post-MRI damaged normal tissue volume   
 
 
Patient 
 
Volume 
(cm3) 
 
 
% Dose  
Phys.1 
 
% Dose  
Phys.2 
 
% Dose  
Phys.3 
 
% Dose 
kNN 
 
% Dose  
KG 
  
%Dose 
TXPlan 
 
1 
 
6.5 
 
99.4 
 
99.4 
 
99.4 
 
99.4 
 
N/A 
 
101.1 
 
2 
 
26.3 
 
98.9 
 
99.4 
 
99.4 
 
99.4 
 
N/A 
 
98.9 
 
3 
 
28.7 
 
97.0 
 
97.0 
 
96.5 
 
96.5 
 
N/A 
 
100.0 
 
6 
 
12.7 
 
102.5 
 
102.5 
 
102.5 
 
102.5 
 
N/A 
 
102.0 
 
8 
 
78.2 
 
98.0 
 
98.0 
 
98.0 
 
96.5 
 
97.0 
 
91.5 
 
9 
 
30.6 
 
101.0 
 
100.5 
 
101.0 
 
101.0 
 
91.5 
 
101.5 
 
10 
 
22.3 
 
88.9 
 
92.2 
 
91.7 
 
89.4 
 
93.3 
 
68.3 
 
11 
 
11.5 
 
100.0 
 
100.0 
 
100.0 
 
100.0 
 
100.0 
 
103.0 
 
 
Ave. 
 
27.1 
± 22.4 
 
98.2 
± 4.1 
 
98.6 
± 3.1 
 
98.6 
± 3.3 
 
98.1 
± 4.1 
 
N/A 
 
95.8 
± 11.7 
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IV.11.  Discussion 
 In Chapter II it was shown that the in-plane contour extraction process allowed 
reasonable gross tumor volume outlines, but left the computer segmentation GTVs 
lacking in the slices immediately above and below the volume.  Using this insight, the 
results from the computer segmentation methods were modified vertically to compensate 
for their under-segmentation by mimicking the process used by the physicians to contour 
the most superior and inferior tumor volume outlines.  This expert knowledge could be 
automatically applied to the segmentation method routine.   
A planning target volume was determined using the automatic margin expansion 
technique.  It was found that it provided volumes comparable to those of the reference 
physician (PTV1).  This was the result of both the modification of the vertical extension 
of the resulting automated GTV volume and the averaging effect of the volume 
expansion technique used for the creation of the planning target volume.  The rolling-ball 
algorithm averaged the differences found in original contouring of the GTV, which were 
mostly at the edges.   
  The resulting treatment plans from both physician and computer segmentation 
PTVs were evaluated and compared to the plan resulting from physician 1 PTV.  Only 
the cone down treatment plan was evaluated since the treatment volume generated for 
this plan is based solely on the GTV.  In this study, there was no evaluation of the 
capabilities of the segmentation methods to identify edema.  Further studies are required 
to identify the accuracy of edema outlining and the consequences for the initial planning 
target volume.  Nevertheless, the use of the GTV volume is appropriate since the GTV 
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receives the greatest radiation dose and is the most important volume in radiation therapy 
planning.  Studies addressing the issue of dose escalation concentrate in delivering higher 
dose of radiation solely to the gross tumor volume.  No efforts are taken to cover areas of 
edema for these escalation protocols (3,7). 
The treatment plans designed from operator defined tumor volumes with 
treatment plans developed using computer segmentations were compared based on dose 
statistics, dose volume histograms, and conformity indices.  All comparisons were made 
with respect of the coverage of the reference physician volume, PTV1.  The dose 
statistics provided a measure of the differences between physicians and automatic 
segmentations in terms of delivered dose.  The results indicated a good target coverage.  
A slight under-dosage was found from the kNN and KG treatment plans in less than 5% 
of the total PTV volume indicating no significant possible clinical effects.  An analysis of 
how much normal brain tissue would be irradiated based on the dose volume histogram 
showed no significant difference between the different treatment plans. 
All treatment plans were created without modification of beam aperture to 
eliminate human bias intervention.  Nevertheless, conformity indices showed adequate 
results for all plans.  A comparison of the data showed a better conformity for treatment 
plans with a higher number of fields, as shown by previous research (48).   
A novel modified definition of a conformity index, referenced herein as cross-
conformity indices, was introduced to calculate the conformity of dose coverage to the 
reference target volume resulting from a plan generated from a computer segmentation or 
physician contour.   The traditional CI comparisons are used to evaluate different 
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treatment plan modalities that were developed based on the same target (47).  For this case, 
the CCIs were used to compare plans created on other targets and superimposing their 
coverage on a reference target.  The same level of conformity was found for the dose 
distributions resulting from the different treatment plans.  This analysis showed that the 
plans generated from the computer segmentations were acceptable to treat the outline 
generated by the reference physician and could have been used in a clinical situation. 
A novel evaluation mechanism based on follow-up imaging was developed to 
validate the results of the hypothetical treatment plans based on the outcome of the actual 
clinical patient treatment.  The method presented utilizes existing imaging modalities for 
the patients under consideration, but the evaluation scheme could be applied to any 
imaging modality. The results showed that the segmentation plans provide similar dose 
coverage to areas being treated by the original treatment plans. 
It can be seen that the automated systems evaluated in this study produced 
treatment plans consistent with the reference radiation oncologist.  Additionally, accuracy 
of the dose coverage was validated by comparing the hypothetical treated areas with the 
actual patient treated areas.  This was the result of the modification of the vertical 
extension of the resulting automated GTV volume and the averaging effect of the volume 
expansion technique used for the creation of the planning target volume.  This 
mechanism shows that automated computer segmentation methods could be a viable tool 
in radiation therapy treatment planning. 
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CHAPTER V 
 
CONCLUSIONS 
Despite advances in diagnosis and treatment modalities, the prognosis for patients 
with brain tumors remains poor.  Malignant gliomas are the most frequent primary brain 
tumors encountered in the adult age group and represent a major cause of mortality in 
neurological practice.  Surgery followed by radiation therapy remains the primary 
therapeutic approach for most brain tumors.  This type of tumor infiltrates normal brain 
tissues quite deeply, making complete surgical resection virtually impossible. Therefore, 
radiation therapy remains the most effective postoperative treatment for these patients. 
Radiation therapy attempts to minimize radiation dose to normal brain tissue 
while delivering the highest possible dose to the target volume.  Recent studies indicate 
that under-irradiation is a major contributor to the relatively poor success rate in treating 
glioma patients.  The current efficacy of radiotherapy is limited since these tumors are 
highly resistant to radiation.  This has motivated the exploration of escalating the dose 
delivered to the tumor bed, where the majority of treatment failures occur.  The proper 
detection of tumor volume is a pre-requisite for such dose escalation.  However, these 
tumors are infiltrative in nature and the definition of tumor margins is extremely difficult.   
The need for improvements was identified when evaluating the current practice of 
tumor volume definition by radiation oncologists.  Our findings indicate that the current 
technique of manual tumor outlining is time-intensive and highly subjective resulting in a 
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large variability between different physicians, even among outlines produced by the same 
physician when faced with the same data at different points in time.  The use of 
automated computer segmentation algorithms as a tool to improve the efficiency, 
accuracy, and reproducibility of tumor definition in radiation treatment planning presents 
one possible solution to this problem.   
This study investigated the application of two state-of-the-art automated tumor 
segmentation methods as tools for tumor volume definition for radiation therapy, kNN as 
a representative of the operator assisted semi-automated method and KG as a candidate 
for the fully automated method.  Although not yet perfected enough for stand-alone use 
in a clinical setting in their current incarnations, automated MRI segmentation systems 
hold the promise of integrating data from multiple sequences to define tumor volumes for 
brain radiotherapy with a greater degree of precision and in a more consistent manner 
than outlining by radiation oncologists.  
In the course of this study, various algorithms were developed to integrate the 
results from the automated computer segmentations techniques with radiation therapy 
treatment planning.  These included the extraction of volume of interest, the manipulation 
of image data and segmentation results to match the treatment planning coordinate 
system, the extraction of contour points, and the formatting of the contour files to include 
the results of the segmentations in the treatment planning software.  
An evaluation of the resulting automated contours showed that the kNN method 
performed better than the KG, probably due to its user input for initial selection of 
training data.  The completely automated KG method was limited to enhancing tumors 
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and gliomas which exhibited clear enhancing edges.  There is need for more work on the 
KG method to make it fully compatible for use in radiation therapy, including 
modifications to permit contouring of partially enhancing tumors, resection cavities and 
non-enhancing tumors.  
The study assessed the viability of the resulting automated contours with the 
contours from radiation oncologists by introducing a novel, probabilistic measurement of 
accuracy.  Starting with the assumption that the true target volume is found through the 
consensus of expert radiation oncologists, the results demonstrated that the kNN and KG 
methods under-segment the tumor volume compared with the physicians but are within 
the variability of the contouring performed by experienced radiation oncologists based on 
the same data.  Additionally, it was found that the contouring produced by both of the 
automated segmentation systems became increasingly less accurate as the contouring 
moved from the central regions of a tumor towards its edges.  The largest discrepancy 
was found at the vertical edges of the GTV.  These results led to the proposed 
modifications to the results obtained from the kNN and KG routines that made them 
significantly more useful for creating radiation therapy treatment plans through an 
improvement in tumor delineation near the vertical axes to compensate for their 
consistent under-segmentation in these regions.   
The next step in the study was to compare the gross tumor volumes (with vertical 
enhancements) produced by the automated systems with those produced from identical 
data by experienced radiation oncologists in a hypothetical clinical setting.  This analysis 
compared the cone down radiation treatment plans designed from the physician defined 
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tumor volumes with similar plans developed from the modified segmentation results 
produced by the automated system.  The comparison showed that the treatment plans 
based on both sets of tumor volume definitions resulted in dose coverage to the reference 
planning target volume within the same level of conformity as presented in Chapter IV.  
Only the cone down treatment plan was evaluated since the treatment volume generated 
for this type of plan is based solely on the gross tumor volume.  Nevertheless, the use of 
the GTV volume is appropriate since the GTV receives the greatest radiation dose and is 
the most important volume in radiation therapy dose escalation studies.   
A validation mechanism was designed to determine the accuracy of the results 
from the segmentation treatment plans with the original patient treatment plans.  This 
evaluation scheme was based on existing follow-up MRI imaging but could be applied to 
any imaging modality.  The results showed that the plans produced using the images 
generated by the automated systems provide similar dose coverage to the target areas as 
those produced using the images provided by the radiation oncologists. 
Based on the results of this study it can be seen that the current level of 
sophistication of the automated systems is insufficient for them to replace the contouring 
generated by radiation oncologists; however, it is also apparent that with the continued 
evolution of these systems, they are likely to reach a level of expertise in contouring 
which will eventually be close to that of experienced radiation oncologists in accuracy 
and exceed it in consistency.  Even in their current incarnations, the automated systems 
produced treatment plans in this study of comparable efficacy to those produced by the 
physicians.   Thus combining the information obtained from the segmentation methods 
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could help radiation oncologists (especially those with limited experience) identify the 
target volume with greater accuracy and produce three-dimensional tumor volume 
models which would be more consistent and reproducible than those currently produced 
by different physicians or at different facilities.  Automatic tumor outlining has the 
potential to speed the contouring process in radiation treatment planning and aid in multi-
center trials since it would prevent physician- and center- bias that can affect trial 
outcomes.  
This study was the first attempt at identifying and designing the steps needed to 
incorporate automatic brain tumor delineation in radiation therapy and the evaluation 
mechanisms to identify their success in treatment planning.  Based on the foregoing, 
improvements are clearly needed to each of the elements of the proposed automatic 
segmentation systems to reach the goal of fully automatic GTV determination for 
radiation therapy treatment planning.  This study has identified certain areas for 
improvement and made suggestions to address some of these areas.  However, this study 
has also shown, through quantitative and qualitative analysis, that the long-term goal of 
fully automatic tumor delineation for glioma radiation treatment planning is not just 
theoretically possible, but is likely to be achieved within the next decade as others with 
more specific expertise in the relevant fields will build on this research in the future.  
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Appendix A:  Intra- and inter- operator variability 
 
The intra-operator variability was calculated as the ratio of the average 
disagreement, that is, the size of each volume minus the intersection of the three volumes, 
divided by the average size of the three volumes.  This calculation is represented in 
following figure:     
       
Vi(int)          Vi1
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Figure A1 
Representation of intra-operator variability calculation 
 
In the above figure, Vi1, Vi2,Vi3 indicate tumor volume delineated by the radiation 
oncologist i three times and shaded area Vi(int) represents the intersection of all 3 
volumes.  This results in the following formula to calculate the intra-operator variability: 
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The inter-operator variability was calculated using the nine sets of outlines for 
each of the eleven patients and then calculating the disagreement from the outline 
prepared by each physician for each patient with the corresponding outline prepared by 
each of the other two physicians for that same patient.  Figure A2 shows the disagreement 
of one volume of one physician i (Vi1) with one volume of another physician j (Vj1). 
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Appendix A  (Continued) 
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Figure A2  
Representation of inter-operator variability calculation 
 
 
The final intra-operator variability is the average of the comparison of all volumes 
of one physician with all the volumes of the other physician as shown in the following 
formula:  
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This calculation is done for each of the three physicians resulting in the average 
variability between the three contours for each patient prepared by one physician with the 
other six sets of contours prepared by the other two physicians for that same patient.  
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Appendix B:  Calculation of accuracy 
 
Accuracy was calculated by assuming that the probability that a region is part of 
the definition of gross tumor volume is reflected by the number of times that region is 
included in any of the nine outline volumes produced by the three radiation oncologists.  
Every pixel in the image is labeled with an integer value (0 to 9) corresponding to the 
number of physician contours in which it was included.  This pixel label provides the 
weight for measuring accuracy.  Figure B1 shows a single volume of either physician 
(Vij) or segmentation (Vk) compared with three (out of the nine) physician volumes.  An 
area of higher pixel label weight is represented by level of gray in the figure, i.e. the area 
where the single volume being evaluated intersects more physician contours:  
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Figure B1 
Representation of accuracy calculation 
 
Final accuracy or true-positive is then expressed as the ratio of the total sum of 
pixel weights that was included by the physician or segmentation volume (Vij or Vk, 
showed as shaded areas in previous figure) to the total sum of pixel weights of the nine  
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Appendix B  (Continued) 
volumes produced by the physicians (represented by all area enclosed by the three 
volumes Vi1, Vi2 and Vi3 in Figure B1): 
 
%100*
9
1
9
1*)or  (
  3
1
3
1
3
1
3
1
)or  ( ∑ ∑∑
∑ ∑∑
==
==
=
pixels
image j
ij
i
pixels
image j
ij
i
kij
VV
V
VVV
Accuracy
kij
           Equation [B.1] 
 
 
Similarly, excluded accuracy or false-positive is expressed as: 
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Appendix C:  IDL software programs 
IDL software programs used throughout this dissertation can be found by 
enclosed CD-rom or by the enclosed file link.   
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